Emergency Medicine: Recent Episodes
ReachMD
Guest: Divya Shankar, MD
A recent study investigated whether pulse-dose corticosteroids offer a benefit over lower doses in managing acute exacerbations of idiopathic pulmonary fibrosis (IPF). Join Dr. Divya Shankar as she explains the real-world data, variability in prescribing patterns, and outcomes observed in different levels of care. Divya Shankar is an Assistant Professor of Medicine at Boston University Chobanian and Avedisian School of Medicine as well as a Pulmonary and Critical Care Physician at Boston Medical Center, and she spoke about this topic at the 2025 American Thoracic Society International Conference.
Host: James R. Bateman, MD, MPH
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), requiring a collaborative, interdisciplinary approach. This program, "Clinical Conundrums: Navigating Case Scenarios in Your Own Practice Setting," offers healthcare professionals concise, case-based microlearning episodes—each approximately 5 minutes long—designed to fit seamlessly into busy schedules. With real-world scenarios and expert-led discussions, this activity provides practical strategies to address diagnostic, monitoring, and therapeutic considerations, equipping participants to optimize patient care and outcomes in their respective fields.
Host: James R. Bateman, MD, MPH
Guest: B. Joy Snider, MD, PhD
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), requiring a collaborative, interdisciplinary approach. This program, "Clinical Conundrums: Navigating Case Scenarios in Your Own Practice Setting," offers healthcare professionals concise, case-based microlearning episodes—each approximately 5 minutes long—designed to fit seamlessly into busy schedules. With real-world scenarios and expert-led discussions, this activity provides practical strategies to address diagnostic, monitoring, and therapeutic considerations, equipping participants to optimize patient care and outcomes in their respective fields.
Host: James R. Bateman, MD, MPH
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), requiring a collaborative, interdisciplinary approach. This program, "Clinical Conundrums: Navigating Case Scenarios in Your Own Practice Setting," offers healthcare professionals concise, case-based microlearning episodes—each approximately 5 minutes long—designed to fit seamlessly into busy schedules. With real-world scenarios and expert-led discussions, this activity provides practical strategies to address diagnostic, monitoring, and therapeutic considerations, equipping participants to optimize patient care and outcomes in their respective fields.
Host: James R. Bateman, MD, MPH
Guest: B. Joy Snider, MD, PhD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), requiring a collaborative, interdisciplinary approach. This program, "Clinical Conundrums: Navigating Case Scenarios in Your Own Practice Setting," offers healthcare professionals concise, case-based microlearning episodes—each approximately 5 minutes long—designed to fit seamlessly into busy schedules. With real-world scenarios and expert-led discussions, this activity provides practical strategies to address diagnostic, monitoring, and therapeutic considerations, equipping participants to optimize patient care and outcomes in their respective fields.
Host: James R. Bateman, MD, MPH
Guest: B. Joy Snider, MD, PhD
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), requiring a collaborative, interdisciplinary approach. This program, "Clinical Conundrums: Navigating Case Scenarios in Your Own Practice Setting," offers healthcare professionals concise, case-based microlearning episodes—each approximately 5 minutes long—designed to fit seamlessly into busy schedules. With real-world scenarios and expert-led discussions, this activity provides practical strategies to address diagnostic, monitoring, and therapeutic considerations, equipping participants to optimize patient care and outcomes in their respective fields.
Host: James R. Bateman, MD, MPH
Guest: B. Joy Snider, MD, PhD
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), requiring a collaborative, interdisciplinary approach. This program, "Clinical Conundrums: Navigating Case Scenarios in Your Own Practice Setting," offers healthcare professionals concise, case-based microlearning episodes—each approximately 5 minutes long—designed to fit seamlessly into busy schedules. With real-world scenarios and expert-led discussions, this activity provides practical strategies to address diagnostic, monitoring, and therapeutic considerations, equipping participants to optimize patient care and outcomes in their respective fields.
Host: James R. Bateman, MD, MPH
Guest: Jerome A. Barakos, MD
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), requiring a collaborative, interdisciplinary approach. This program, "Clinical Conundrums: Navigating Case Scenarios in Your Own Practice Setting," offers healthcare professionals concise, case-based microlearning episodes—each approximately 5 minutes long—designed to fit seamlessly into busy schedules. With real-world scenarios and expert-led discussions, this activity provides practical strategies to address diagnostic, monitoring, and therapeutic considerations, equipping participants to optimize patient care and outcomes in their respective fields.
Host: James R. Bateman, MD, MPH
Guest: Charles P. Vega, MD
Guest: B. Joy Snider, MD, PhD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), requiring a collaborative, interdisciplinary approach. This program, "Clinical Conundrums: Navigating Case Scenarios in Your Own Practice Setting," offers healthcare professionals concise, case-based microlearning episodes—each approximately 5 minutes long—designed to fit seamlessly into busy schedules. With real-world scenarios and expert-led discussions, this activity provides practical strategies to address diagnostic, monitoring, and therapeutic considerations, equipping participants to optimize patient care and outcomes in their respective fields.
Host: James R. Bateman, MD, MPH
Guest: B. Joy Snider, MD, PhD
Guest: Charles P. Vega, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), requiring a collaborative, interdisciplinary approach. This program, "Clinical Conundrums: Navigating Case Scenarios in Your Own Practice Setting," offers healthcare professionals concise, case-based microlearning episodes—each approximately 5 minutes long—designed to fit seamlessly into busy schedules. With real-world scenarios and expert-led discussions, this activity provides practical strategies to address diagnostic, monitoring, and therapeutic considerations, equipping participants to optimize patient care and outcomes in their respective fields.
Host: James R. Bateman, MD, MPH
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Guest: B. Joy Snider, MD, PhD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), requiring a collaborative, interdisciplinary approach. This program, "Clinical Conundrums: Navigating Case Scenarios in Your Own Practice Setting," offers healthcare professionals concise, case-based microlearning episodes—each approximately 5 minutes long—designed to fit seamlessly into busy schedules. With real-world scenarios and expert-led discussions, this activity provides practical strategies to address diagnostic, monitoring, and therapeutic considerations, equipping participants to optimize patient care and outcomes in their respective fields.
Host: James R. Bateman, MD, MPH
Guest: B. Joy Snider, MD, PhD
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), requiring a collaborative, interdisciplinary approach. This program, "Clinical Conundrums: Navigating Case Scenarios in Your Own Practice Setting," offers healthcare professionals concise, case-based microlearning episodes—each approximately 5 minutes long—designed to fit seamlessly into busy schedules. With real-world scenarios and expert-led discussions, this activity provides practical strategies to address diagnostic, monitoring, and therapeutic considerations, equipping participants to optimize patient care and outcomes in their respective fields.
Host: James R. Bateman, MD, MPH
Guest: Jerome A. Barakos, MD
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Guest: B. Joy Snider, MD, PhD
Guest: Charles P. Vega, MD
Amyloid-related imaging abnormalities (ARIA) can pose a significant challenge in the management of Alzheimer's disease, necessitating a collaborative, interdisciplinary approach. "The ARIA Toolkit: An Interdisciplinary Curriculum" is a comprehensive program designed to equip healthcare professionals with in-depth knowledge and practical skills for effective ARIA management. Featuring the latest advances in anti-amyloid beta monoclonal antibodies (anti-Aβ mAbs), this educational format aims to prepare participants for real-world scenarios. Join our panel of expert faculty in this essential session to enhance team-based strategies and optimize patient outcomes.
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform clinical practice.
Guest: Manesh R. Patel, MD
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform clinical practice.
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform clinical practice.
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform clinical practice.
Host: Hiren C. Patel, PhD, FRCS
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Adrian R. Parry-Jones, FRCP, PhD
Host: Thorsten Steiner, MD, PhD, MME
Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.
Host: David Seiffge, MD
Host: Natalie Kreitzer, MD, MS
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.
Host: Natalie Kreitzer, MD, MS
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Thorsten Steiner, MD, PhD, MME
Host: Adrian R. Parry-Jones, FRCP, PhD
Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.
Host: Thorsten Steiner, MD, PhD, MME
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: David Seiffge, MD
Host: Adrian R. Parry-Jones, FRCP, PhD
Host: Natalie Kreitzer, MD, MS
Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.
Host: Adrian R. Parry-Jones, FRCP, PhD
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Hiren C. Patel, PhD, FRCS
Host: David Seiffge, MD
Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Natalie Kreitzer, MD, MS
Host: Adrian R. Parry-Jones, FRCP, PhD
Host: Hiren C. Patel, PhD, FRCS
Host: David Seiffge, MD
Host: Thorsten Steiner, MD, PhD, MME
Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.
Host: Manesh R. Patel, MD
This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.
Host: Manesh R. Patel, MD
This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.
Host: Marc P. Bonaca, MD, MPH
This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.
Host: Marc P. Bonaca, MD, MPH
This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.
Host: Daniel Gaudet, MD, PhD
This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Henry Rosenberg, MD
Malignant hyperthermia is an inherited disorder primarily recognized by anesthesia professionals. And since this condition can have significant consequences on a patient’s health, including their likelihood of surviving surgery, it’s important to know how to diagnose and treat malignant hyperthermia emergencies in operating room settings. Join Dr. Charles Turck as he dives deeper into this topic with Dr. Henry Rosenberg, a member of the Board of Directors of the Malignant Hyperthermia Association of the United States.
Guest: Erick Tarula, MD
Many complications can occur in hospitalized neurological patients from an internal medicine standpoint. So a session from the 2024 Academy of American Neurology (AAN) Annual Meeting focused on these common issues, how they can be addressed quickly, and the role of a neurohospitalist. Dive in further with Dr. Erick Tarula, Assistant Professor in the Department of Neurology at the University of Wisconsin School of Medicine and Public Health.
Host: Eliza C. Miller, MD
Stroke is one of the leading causes of death in pregnancy in the United States, underscoring the importance of knowing the causes, risks, and treatment of stroke in pregnancy and postpartum. That’s why Dr. Eliza Miller is here to share key insights from her session at the 2024 AAN Annual Meeting that focused on this exact topic. Dr. Miller is an Associate Professor of Neurology in the Division of Stroke and Cerebrovascular Disease at Columbia University.
Host: Caitlin Costello, MD
Guest: Sagar Lonial, MD, FACP
Bispecific antibodies are the newest immunotherapies approved for heavily pretreated relapsed/refractory myeloma, and they are shown to double response rates. Are you ready to use them in your practice? Join Drs. Costello and Lonial as they explore a case study that demonstrates how to select patients, prepare them for treatment, and effectively manage treatment-related side effects.
Host: Caitlin Costello, MD
Guest: Sagar Lonial, MD, FACP
Dive into the cutting-edge realm of bispecific antibodies for relapsed/refractory multiple myeloma with our experts, Dr. Caitlin Costello and Dr. Sagar Lonial. They explore the efficacy, safety, and practical integration of bispecific antibodies into clinical practice. Tune in to gain invaluable insights on optimizing patient care and navigating treatment-related adverse events to elevate your oncology practice.
Host: Sagar Lonial, MD, FACP
Guest: Caitlin Costello, MD
"Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to the approval of these agents for relapsed myeloma.
Host: Sagar Lonial, MD, FACP
Guest: Caitlin Costello, MD
"Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to the approval of these agents for relapsed myeloma.
Host: Sagar Lonial, MD, FACP
Guest: Caitlin Costello, MD
"Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to the approval of these agents for relapsed myeloma.
Host: Sagar Lonial, MD, FACP
Guest: Caitlin Costello, MD
"Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to the approval of these agents for relapsed myeloma.
Host: Sagar Lonial, MD, FACP
Guest: Caitlin Costello, MD
"Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to the approval of these agents for relapsed myeloma.
Host: Sagar Lonial, MD, FACP
"Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to the approval of these agents for relapsed myeloma.
Host: Sagar Lonial, MD, FACP
Guest: Caitlin Costello, MD
"Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to the approval of these agents for relapsed myeloma.
Host: Sagar Lonial, MD, FACP
Guest: Caitlin Costello, MD
"Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to the approval of these agents for relapsed myeloma.
Host: Sagar Lonial, MD, FACP
Guest: Caitlin Costello, MD
"Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to the approval of these agents for relapsed myeloma.
Host: Sagar Lonial, MD, FACP
Guest: Caitlin Costello, MD
"Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to the approval of these agents for relapsed myeloma.
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Adrian R. Parry-Jones, FRCP, PhD
Host: Stuart Connolly, MD, FRCPC
Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Greg Albers, MD
Host: Rhonda Cadena, MD, FNCS, FCCM
Host: Adrian R. Parry-Jones, FRCP, PhD
Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Rhonda Cadena, MD, FNCS, FCCM
Host: Adrian R. Parry-Jones, FRCP, PhD
Host: Stuart Connolly, MD, FRCPC
Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Natalie Kreitzer, MD, MS
Host: Adrian R. Parry-Jones, FRCP, PhD
Host: Rhonda Cadena, MD, FNCS, FCCM
Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Stuart Connolly, MD, FRCPC
Host: Rhonda Cadena, MD, FNCS, FCCM
Host: Greg Albers, MD
Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.
Host: Annie Levesque, MD, MSc
Guest: Ethan A. Cowan, MD
Alcohol use disorder, or AUD, is a rising health crisis that often goes undiagnosed. And many patients that are diagnosed with AUD do not receive appropriate pharmacologic intervention or even a referral. Join Drs. Levesque and Cowan in this case-based educational program as they provide critical diagnostic and treatment strategies for use in the office/clinic setting and the Emergency Department.
Host: Elaine Hylek, MD, MPH
Anticoagulation has transformed the management of multiple potentially catastrophic disease states. Currently, available anticoagulation agents work on the common pathway of the coagulation cascade, inhibiting both thrombosis as well as hemostasis and increasing the risk of serious bleeding. Factor XIa inhibitors may completely change this anticoagulation landscape. Factor XIa affects the intrinsic thrombosis pathway, preserving the extrinsic and common pathways. Phase 2 data on multiple factor XIa inhibitors support a favorable safety profile for implementation, with reduced risk of bleeding being a consistent theme, for VTE prophylaxis, secondary stroke prevention in atrial fibrillation (AF), post-myocardial infarction (MI), and post-non-embolic stroke. This program explores novel factor XIa inhibitors currently under investigation and outlines anticoagulation’s exciting future.
Host: Manesh R. Patel, MD
Host: M. Cecilia Bahit, MD
Host: Elaine Hylek, MD, MPH
Anticoagulation has transformed the management of multiple potentially catastrophic disease states. Currently, available anticoagulation agents work on the common pathway of the coagulation cascade, inhibiting both thrombosis as well as hemostasis and increasing the risk of serious bleeding. Factor XIa inhibitors may completely change this anticoagulation landscape. Factor XIa affects the intrinsic thrombosis pathway, preserving the extrinsic and common pathways. Phase 2 data on multiple factor XIa inhibitors support a favorable safety profile for implementation, with reduced risk of bleeding being a consistent theme, for VTE prophylaxis, secondary stroke prevention in atrial fibrillation (AF), post-myocardial infarction (MI), and post-non-embolic stroke. This program explores novel factor XIa inhibitors currently under investigation and outlines anticoagulation’s exciting future.
Host: Christopher B. Granger, MD
Anticoagulation has transformed the management of multiple potentially catastrophic disease states. Currently, available anticoagulation agents work on the common pathway of the coagulation cascade, inhibiting both thrombosis as well as hemostasis and increasing the risk of serious bleeding. Factor XIa inhibitors may completely change this anticoagulation landscape. Factor XIa affects the intrinsic thrombosis pathway, preserving the extrinsic and common pathways. Phase 2 data on multiple factor XIa inhibitors support a favorable safety profile for implementation, with reduced risk of bleeding being a consistent theme, for VTE prophylaxis, secondary stroke prevention in atrial fibrillation (AF), post-myocardial infarction (MI), and post-non-embolic stroke. This program explores novel factor XIa inhibitors currently under investigation and outlines anticoagulation’s exciting future.
Host: Manesh R. Patel, MD
Anticoagulation has transformed the management of multiple potentially catastrophic disease states. Currently, available anticoagulation agents work on the common pathway of the coagulation cascade, inhibiting both thrombosis as well as hemostasis and increasing the risk of serious bleeding. Factor XIa inhibitors may completely change this anticoagulation landscape. Factor XIa affects the intrinsic thrombosis pathway, preserving the extrinsic and common pathways. Phase 2 data on multiple factor XIa inhibitors support a favorable safety profile for implementation, with reduced risk of bleeding being a consistent theme, for VTE prophylaxis, secondary stroke prevention in atrial fibrillation (AF), post-myocardial infarction (MI), and post-non-embolic stroke. This program explores novel factor XIa inhibitors currently under investigation and outlines anticoagulation’s exciting future.
Host: M. Cecilia Bahit, MD
Anticoagulation has transformed the management of multiple potentially catastrophic disease states. Currently, available anticoagulation agents work on the common pathway of the coagulation cascade, inhibiting both thrombosis as well as hemostasis and increasing the risk of serious bleeding. Factor XIa inhibitors may completely change this anticoagulation landscape. Factor XIa affects the intrinsic thrombosis pathway, preserving the extrinsic and common pathways. Phase 2 data on multiple factor XIa inhibitors support a favorable safety profile for implementation, with reduced risk of bleeding being a consistent theme, for VTE prophylaxis, secondary stroke prevention in atrial fibrillation (AF), post-myocardial infarction (MI), and post-non-embolic stroke. This program explores novel factor XIa inhibitors currently under investigation and outlines anticoagulation’s exciting future.
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Tobias Lindner, MD
This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.
Host: Natalie Kreitzer, MD, MS
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Susann Järhult, MD
Host: Martin Möckel, MD, PhD
This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Adrian R. Parry-Jones, FRCP, PhD
This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.
Host: Adrian R. Parry-Jones, FRCP, PhD
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Martin Möckel, MD, PhD
Host: Richard Body, MB ChB, PhD
This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Vinay Sehgal, MBChB, MRCP, PhD
This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Natalie Kreitzer, MD, MS
This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.
Host: Vinay Sehgal, MBChB, MRCP, PhD
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Susann Järhult, MD
Host: Martin Möckel, MD, PhD
This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.
Host: Tobias Lindner, MD
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
Host: Susann Järhult, MD
Host: Richard Body, MB ChB, PhD
This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.
Guest: Terry M. Foster, MSN, RN, CEN, CPEN, CCRN, TCRN, FAEN
Attendees can expect a wide range of education sessions, keynote presentations, networking events, and hands-on learning experiences from this year’s Emergency Nurses Association (ENA) annual meeting. Hear from ENA President, Terry Foster, Critical-Care Clinical Nurse Specialist in the Emergency Departments at St. Elizabeth Healthcare, a Magnet-Designated Hospital, in Northern Kentucky, as he shares more details on the upcoming 2023 meeting.
Host: Jennifer Caudle, DO
Guest: Michelle Kincaid, MD
The largest study to date on 4F-PCC was conducted as an FDA postmarketing requirement in partnership between Kaiser Permanente and CSL Behring. The purpose of this long-term study was to compare the 45-day risk of thromboembolic events and all-cause mortality in adults with warfarin-associated major bleeding after treatment with KCENTRA®, Prothrombin Complex Concentrate (Human), or plasma. Take a deep dive into the data with Dr. Jennifer Caudle as she speaks with Dr. Michelle Kincaid, Trauma Surgeon and Director of Surgical Critical Care at Ohio Health Grant Medical Center in Columbus.
Host: James Galvin, MD, MPH, FANA
Guest: Gloria Chiang, MD
Guest: Christopher Carpenter, MD, MSC, FACEP, FAAEM, AGSF
Guest: Charles P. Vega, MD
Recently, Alzheimer’s Disease (AD) saw its first approvals for disease modifying therapy (DMT). With amyloid-beta (Aβ) targeting DMT now a reality, the entire way this condition is viewed and managed is changing. In particular, amyloid-related imaging abnormalities (ARIA), the most common adverse effects seen in DMT trials, are unique to this agent class, raising new questions and considerations across multiple medical specialties. As there is limited formal guidance on how to recognize and mange ARIA, this activity series employs experts in the fields of neurology, radiology, emergency medicine, and primary care to provide insight into how their fields are evolving to accommodate ARIA and to outline individual roles and best practices across specialties. This activity is part of a series of six distinct programs designed to introduce ARIA, detail its recognition and management in specific clinical settings, and ultimately optimize collaborative care.
This activity finishes out the series by first providing an abbreviated outline of what has been addressed across activities 1-5 followed by a multidisciplinary discussion of questions and considerations that may impact the team-based execution of discussed strategies.
Host: James Galvin, MD, MPH, FANA
Guest: Gloria Chiang, MD
Guest: Christopher Carpenter, MD, MSC, FACEP, FAAEM, AGSF
Recently, Alzheimer’s Disease (AD) saw its first approvals for disease modifying therapy (DMT). With amyloid-beta (Aβ) targeting DMT now a reality, the entire way this condition is viewed and managed is changing. In particular, amyloid-related imaging abnormalities (ARIA), the most common adverse effects seen in DMT trials, are unique to this agent class, raising new questions and considerations across multiple medical specialties. As there is limited formal guidance on how to recognize and mange ARIA, this activity series employs experts in the fields of neurology, radiology, emergency medicine, and primary care to provide insight into how their fields are evolving to accommodate ARIA and to outline individual roles and best practices across specialties. This activity is part of a series of six distinct programs designed to introduce ARIA, detail its recognition and management in specific clinical settings, and ultimately optimize collaborative care.
This activity focuses on the role of emergency medicine clinicians in the recognition and management of ARIA. This includes an overview of how ARIA may present to the emergency department and what courses of action to treat/manage ARIA may be needed from the hospital care team.
Host: Sharlena Wilson, MD
This program discusses the need to quickly and accurately recognize the signs and symptoms of agitation in patients with schizophrenia and bipolar disorder and to differentiate agitation from akathisia and other disease therapy-induced symptoms that may mimic it. Agitation can escalate quickly into aggressive and potentially dangerous behavior that puts healthcare personnel (HCP) and families at risk of verbal or bodily harm. Nationally recognized expert consensus best-practice guidelines provide clear direction on how to triage and manage agitation in the emergency room setting, but knowledge and implementation gaps remain. As data emerges for new approaches to treatment, clinicians need to know the novel pharmacological and nonpharmacological options to care for agitation in patients with schizophrenia and bipolar disorder. This program focuses on the recognition and management of agitation, best practices, and novel treatments. It will distill essential information for everyday clinical practice that offers an alternative to the “sedate and restrain” treatment approaches of the past.
Host: Scott Zeller, MD
Guest: Sharlena Wilson, MD
Guest: Michael D. Gooch, DNP, APRN, CCP, ACNP-BC, FNP-BC, ENP-C
This program discusses the need to quickly and accurately recognize the signs and symptoms of agitation in patients with schizophrenia and bipolar disorder and to differentiate agitation from akathisia and other disease therapy-induced symptoms that may mimic it. Agitation can escalate quickly into aggressive and potentially dangerous behavior that puts healthcare personnel (HCP) and families at risk of verbal or bodily harm. Nationally recognized expert consensus best-practice guidelines provide clear direction on how to triage and manage agitation in the emergency room setting, but knowledge and implementation gaps remain. As data emerges for new approaches to treatment, clinicians need to know the novel pharmacological and nonpharmacological options to care for agitation in patients with schizophrenia and bipolar disorder. This program focuses on the recognition and management of agitation, best practices, and novel treatments. It will distill essential information for everyday clinical practice that offers an alternative to the “sedate and restrain” treatment approaches of the past.
Host: Scott Zeller, MD
Guest: Sharlena Wilson, MD
Guest: Michael D. Gooch, DNP, APRN, CCP, ACNP-BC, FNP-BC, ENP-C
This program discusses the need to quickly and accurately recognize the signs and symptoms of agitation in patients with schizophrenia and bipolar disorder and to differentiate agitation from akathisia and other disease therapy-induced symptoms that may mimic it. Agitation can escalate quickly into aggressive and potentially dangerous behavior that puts healthcare personnel (HCP) and families at risk of verbal or bodily harm. Nationally recognized expert consensus best-practice guidelines provide clear direction on how to triage and manage agitation in the emergency room setting, but knowledge and implementation gaps remain. As data emerges for new approaches to treatment, clinicians need to know the novel pharmacological and nonpharmacological options to care for agitation in patients with schizophrenia and bipolar disorder. This program focuses on the recognition and management of agitation, best practices, and novel treatments. It will distill essential information for everyday clinical practice that offers an alternative to the “sedate and restrain” treatment approaches of the past.
Host: Sharlena Wilson, MD
This program discusses the need to quickly and accurately recognize the signs and symptoms of agitation in patients with schizophrenia and bipolar disorder and to differentiate agitation from akathisia and other disease therapy-induced symptoms that may mimic it. Agitation can escalate quickly into aggressive and potentially dangerous behavior that puts healthcare personnel (HCP) and families at risk of verbal or bodily harm. Nationally recognized expert consensus best-practice guidelines provide clear direction on how to triage and manage agitation in the emergency room setting, but knowledge and implementation gaps remain. As data emerges for new approaches to treatment, clinicians need to know the novel pharmacological and nonpharmacological options to care for agitation in patients with schizophrenia and bipolar disorder. This program focuses on the recognition and management of agitation, best practices, and novel treatments. It will distill essential information for everyday clinical practice that offers an alternative to the “sedate and restrain” treatment approaches of the past.
Host: Michael D. Gooch, DNP, APRN, CCP, ACNP-BC, FNP-BC, ENP-C
This program discusses the need to quickly and accurately recognize the signs and symptoms of agitation in patients with schizophrenia and bipolar disorder and to differentiate agitation from akathisia and other disease therapy-induced symptoms that may mimic it. Agitation can escalate quickly into aggressive and potentially dangerous behavior that puts healthcare personnel (HCP) and families at risk of verbal or bodily harm. Nationally recognized expert consensus best-practice guidelines provide clear direction on how to triage and manage agitation in the emergency room setting, but knowledge and implementation gaps remain. As data emerges for new approaches to treatment, clinicians need to know the novel pharmacological and nonpharmacological options to care for agitation in patients with schizophrenia and bipolar disorder. This program focuses on the recognition and management of agitation, best practices, and novel treatments. It will distill essential information for everyday clinical practice that offers an alternative to the “sedate and restrain” treatment approaches of the past.
Host: Michael D. Gooch, DNP, APRN, CCP, ACNP-BC, FNP-BC, ENP-C
This program discusses the need to quickly and accurately recognize the signs and symptoms of agitation in patients with schizophrenia and bipolar disorder and to differentiate agitation from akathisia and other disease therapy-induced symptoms that may mimic it. Agitation can escalate quickly into aggressive and potentially dangerous behavior that puts healthcare personnel (HCP) and families at risk of verbal or bodily harm. Nationally recognized expert consensus best-practice guidelines provide clear direction on how to triage and manage agitation in the emergency room setting, but knowledge and implementation gaps remain. As data emerges for new approaches to treatment, clinicians need to know the novel pharmacological and nonpharmacological options to care for agitation in patients with schizophrenia and bipolar disorder. This program focuses on the recognition and management of agitation, best practices, and novel treatments. It will distill essential information for everyday clinical practice that offers an alternative to the “sedate and restrain” treatment approaches of the past.
Host: Scott Zeller, MD
This program discusses the need to quickly and accurately recognize the signs and symptoms of agitation in patients with schizophrenia and bipolar disorder and to differentiate agitation from akathisia and other disease therapy-induced symptoms that may mimic it. Agitation can escalate quickly into aggressive and potentially dangerous behavior that puts healthcare personnel (HCP) and families at risk of verbal or bodily harm. Nationally recognized expert consensus best-practice guidelines provide clear direction on how to triage and manage agitation in the emergency room setting, but knowledge and implementation gaps remain. As data emerges for new approaches to treatment, clinicians need to know the novel pharmacological and nonpharmacological options to care for agitation in patients with schizophrenia and bipolar disorder. This program focuses on the recognition and management of agitation, best practices, and novel treatments. It will distill essential information for everyday clinical practice that offers an alternative to the “sedate and restrain” treatment approaches of the past.
Host: Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
The introduction and assessment of real-world data (RWD) associated with FXa inhibitor-related bleeds is of critical importance in treatment-emergent situations, as there has been limited information disseminated to date within the relatively complex clinical landscape. This program focuses on the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant and the most recent key real-world data releases that have been published relative to the use of reversal or repletion strategies in the anticoagulated patient. This enduring activity was initially presented as a satellite symposium held during the AC Forum's 17th National Conference on Anticoagulation Therapy on April 2, 2023, in San Francisco, CA.
Host: Mark Crowther, MD, MSc, FRCPC, FRSC
The introduction and assessment of real-world data (RWD) associated with FXa inhibitor-related bleeds is of critical importance in treatment-emergent situations, as there has been limited information disseminated to date within the relatively complex clinical landscape. This program focuses on the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant and the most recent key real-world data releases that have been published relative to the use of reversal or repletion strategies in the anticoagulated patient. This enduring activity was initially presented as a satellite symposium held during the AC Forum's 17th National Conference on Anticoagulation Therapy on April 2, 2023, in San Francisco, CA.
Host: Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
Guest: Mark Crowther, MD, MSc, FRCPC, FRSC
The introduction and assessment of real-world data (RWD) associated with FXa inhibitor-related bleeds is of critical importance in treatment-emergent situations, as there has been limited information disseminated to date within the relatively complex clinical landscape. This program focuses on the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant and the most recent key real-world data releases that have been published relative to the use of reversal or repletion strategies in the anticoagulated patient. This enduring activity was initially presented as a satellite symposium held during the AC Forum's 17th National Conference on Anticoagulation Therapy on April 2, 2023, in San Francisco, CA.
Host: Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
The introduction and assessment of real-world data (RWD) associated with FXa inhibitor-related bleeds is of critical importance in treatment-emergent situations, as there has been limited information disseminated to date within the relatively complex clinical landscape. This program focuses on the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant and the most recent key real-world data releases that have been published relative to the use of reversal or repletion strategies in the anticoagulated patient. This enduring activity was initially presented as a satellite symposium held during the AC Forum's 17th National Conference on Anticoagulation Therapy on April 2, 2023, in San Francisco, CA.
Host: Mark Crowther, MD, MSc, FRCPC, FRSC
The introduction and assessment of real-world data (RWD) associated with FXa inhibitor-related bleeds is of critical importance in treatment-emergent situations, as there has been limited information disseminated to date within the relatively complex clinical landscape. This program focuses on the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant and the most recent key real-world data releases that have been published relative to the use of reversal or repletion strategies in the anticoagulated patient. This enduring activity was initially presented as a satellite symposium held during the AC Forum's 17th National Conference on Anticoagulation Therapy on April 2, 2023, in San Francisco, CA.
Host: Mark Crowther, MD, MSc, FRCPC, FRSC
The introduction and assessment of real-world data (RWD) associated with FXa inhibitor-related bleeds is of critical importance in treatment-emergent situations, as there has been limited information disseminated to date within the relatively complex clinical landscape. This program focuses on the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant and the most recent key real-world data releases that have been published relative to the use of reversal or repletion strategies in the anticoagulated patient. This enduring activity was initially presented as a satellite symposium held during the AC Forum's 17th National Conference on Anticoagulation Therapy on April 2, 2023, in San Francisco, CA.
Host: Edwin A. Salsitz, MD, DFASAM
Guest: Annie Levesque, MD, MSc
The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders worldwide. Our multidisciplinary experts dive into various approaches to the treatment of AUD. Join Drs. Edwin Salsitz, Ethan Cowan, and Annie Levesque as they view AUD through their respective psychiatric, emergency department, and family medicine lenses.
Host: Edwin A. Salsitz, MD, DFASAM
Guest: Ethan A. Cowan, MD
The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders worldwide. Our multidisciplinary experts dive into various approaches to the treatment of AUD. Join Drs. Edwin Salsitz, Ethan Cowan, and Annie Levesque as they view AUD through their respective psychiatric, emergency department, and family medicine lenses.
Guest: Ethan A. Cowan, MD
Guest: Edwin A. Salsitz, MD, DFASAM
The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders worldwide. Our multidisciplinary experts dive into various approaches to the treatment of AUD. Join Drs. Edwin Salsitz, Ethan Cowan, and Annie Levesque as they view AUD through their respective psychiatric, emergency department, and family medicine lenses.
Host: Annie Levesque, MD, MSc
Guest: Edwin A. Salsitz, MD, DFASAM
The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders worldwide. Our multidisciplinary experts dive into various approaches to the treatment of AUD. Join Drs. Edwin Salsitz, Ethan Cowan, and Annie Levesque as they view AUD through their respective psychiatric, emergency department, and family medicine lenses.
Host: Edwin A. Salsitz, MD, DFASAM
Guest: Ethan A. Cowan, MD
The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders worldwide. Our multidisciplinary experts dive into various approaches to the treatment of AUD. Join Drs. Edwin Salsitz, Ethan Cowan, and Annie Levesque as they view AUD through their respective psychiatric, emergency department, and family medicine lenses.
Guest: Edwin A. Salsitz, MD, DFASAM
The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders worldwide. Our multidisciplinary experts dive into various approaches to the treatment of AUD. Join Drs. Edwin Salsitz, Ethan Cowan, and Annie Levesque as they view AUD through their respective psychiatric, emergency department, and family medicine lenses.
Host: Edwin A. Salsitz, MD, DFASAM
Guest: Annie Levesque, MD, MSc
The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders worldwide. Our multidisciplinary experts dive into various approaches to the treatment of AUD. Join Drs. Edwin Salsitz, Ethan Cowan, and Annie Levesque as they view AUD through their respective psychiatric, emergency department, and family medicine lenses.
Guest: Edwin A. Salsitz, MD, DFASAM
The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders worldwide. Our multidisciplinary experts dive into various approaches to the treatment of AUD. Join Drs. Edwin Salsitz, Ethan Cowan, and Annie Levesque as they view AUD through their respective psychiatric, emergency department, and family medicine lenses.
Host: Annie Levesque, MD, MSc
Guest: Ethan A. Cowan, MD
The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders worldwide. Our multidisciplinary experts dive into various approaches to the treatment of AUD. Join Drs. Edwin Salsitz, Ethan Cowan, and Annie Levesque as they view AUD through their respective psychiatric, emergency department, and family medicine lenses.
Guest: Ethan A. Cowan, MD
Guest: Edwin A. Salsitz, MD, DFASAM
The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders worldwide. Our multidisciplinary experts dive into various approaches to the treatment of AUD. Join Drs. Edwin Salsitz, Ethan Cowan, and Annie Levesque as they view AUD through their respective psychiatric, emergency department, and family medicine lenses.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Derrick Barnes, MD
Locum tenens offers physicians the opportunity to work in a variety of environments with a diverse range of patient populations. Dr. Charles Turck sits down with Dr. Derrick Barnes, who has affiliations with the Community Hospital of the Monterey Peninsula and the California Pacific Medical Center Van Ness Campus with Sutter Health, to share his experience with locum tenens.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: W. Frank Peacock, MD
For patients with opioid-induced constipation (OIC), can Narcan play a role in finding a new treatment option? Dr. Charles Turck is joined by Dr. Frank Peacock from the Baylor College of Medicine to explore key data on the role of methylnaltrexone in the treatment of OIC.
Host: Andrea Singer, MD, FACP, CCD
Guest: Paul A. Anderson, MD
Guest: Susan V. Bukata, MD, FAOA, FAAOS
Since the recording of this CME activity, the following updates have been published:
-
NAMS Position Statement on the Management of Osteoporosis in Postmenopausal Women
- Menopause. 2021;28(9):973-997.
-
Consensus Statement from the Bone Health and Osteoporosis Foundation, formerly known as the National Osteoporosis Foundation
- The Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporosis Int. 2022;33(10):2049-2102.
While there’s growing awareness among orthopedic surgeons that osteoporosis is the underlying cause of fractures, there is often a disconnect between this recognition and action in the form of treatment to prevent subsequent fractures. In this discussion, Drs. Andrea Singer, Paul Anderson, and Susan Bukata address the pathophysiology of osteoporosis and the need to identify patients at risk for additional fractures. Osteoporosis treatment (including pharmacotherapy) can play a critical role in preventing future fractures, but physicians must first recognize that fracture is a sentinel event and treat it as a call to action.
Host: Randy Young, MD
Guest: Tufik Assad, MD, MSCI
What are the factors that make diagnosing pneumonia challenging, and how might emerging testing modalities improve that? To answer this question, Dr. Randy Young and Dr. Tufik Assad from the Williamson Medical Center in Franklin, Tennessee dive into the etiology, diagnostic challenges, and current trends in pneumonia diagnostics.
This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by bioMèrieux.
Host: Cem Akin, MD, PhD
Guest: Deepti Radia, MD
Indolent systemic mastocytosis is a rare disease often overlooked in the general healthcare setting. Drs. Deepti Radia and Cem Akin outline diagnostic criteria, signs and symptoms, and diagnostic tests to confirm diagnosis.
Host: Cem Akin, MD, PhD
Guest: Deepti Radia, MD
Indolent systemic mastocytosis is a rare disease often overlooked in the general healthcare setting. Drs. Deepti Radia and Cem Akin outline diagnostic criteria, signs and symptoms, and diagnostic tests to confirm diagnosis.
Host: Cem Akin, MD, PhD
Guest: Jason Gotlib, MD, MS
It could take up to 7 years for a patient to be accurately diagnosed with systemic mastocytosis. Drs. Jason Gotlib and Cem Akin take us through the guidelines, diagnostic criteria, signs and symptoms, and the most important diagnostic tests for high-suspicion patients.
Host: Cem Akin, MD, PhD
Guest: Jason Gotlib, MD, MS
It could take up to 7 years for a patient to be accurately diagnosed with systemic mastocytosis. Drs. Jason Gotlib and Cem Akin take us through the guidelines, diagnostic criteria, signs and symptoms, and the most important diagnostic tests for high-suspicion patients.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Nick Kusnezov, MD
Can you balance locum tenens with a full-time career? To answer that question, Dr. Charles Turck is joined by board-certified orthopedic surgeon, Dr. Nicholas Kusnezov, to walk us through his journey from joining the military to locum tenens.
Host: Jennifer Caudle, DO
Guest: Roni Devlin, MD
As rates of burnout continue to rise in the healthcare community, how can help our female physicians combat it? Dr. Jennifer Caudle joins Infectious Disease Specialist, Dr. Roni Devlin, to discuss how we can prevent burnout for female physicians.
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Charles P. Vega, MD
We now have evidence-based options to reduce atherosclerotic cardiovascular disease (ASCVD) event burden beyond any previously available therapy. A pragmatic approach that addresses residual cardiovascular (CV) risk across a variety of risk factors and that goes beyond LDL-C lowering therapies is needed to optimally manage patients with or at high risk of ASCVD. Pharmacists treating these patients require review of recent data and guidelines so they can incorporate these findings into clinical practice. Join us to ensure you’re keeping up with the science and giving your patients the best care.
Host: Paul P. Doghramji, MD, FAAFP
Guest: Samantha Conroy, MD
Locum tenens can improve quality of care around the globe—especially in remote and underserved communities. To share how, Dr. Paul Doghramji joins Dr. Samantha Conroy, a family practice obstetrician to share her experiences working as a locum tenens obstetrician in underserved communities.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Trevor Cabrera, MD
What’s it like becoming a locum tenens physician right out of residency? Dr. Charles Turck joins Dr. Trevor Cabrera, a Board-Certified pediatrician who trained in Houston, Texas, to share his firsthand experience and offer advice for residents.
Host: Jennifer Caudle, DO
Guest: Maurice G. Sholas, MD, PhD
After years of serving the New Orleans community, one physician decided to pursue locum tenens work. Dr. Jennifer Caudle joins Dr. Maurice Sholas, a pediatric physical rehabilitation physician, to share his experiences with locum tenens and in New Orleans.
Host: Jennifer Caudle, DO
Guest: Leonard A Valentino, MD
Unfortunately, recognizing and diagnosing patients with bleeding disorders is only the first of many challenges. Once a diagnosis is reached, patients may face a variety of chronic health challenges and even altered family dynamics. Fortunately, recent treatments and developments—and even those on the horizon—can help alleviate the burden of bleeding disorders on patients and their loved ones. Join Dr. Jennifer Caudle as she uncovers those important efforts with Dr. Leonard Valentino, President and Chief Executive Officer at the National Hemophilia Foundation.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Sean Lau, RN, VA-BC
What are some ways we can reduce the prevalence of difficult venous access? Dr. Charles Turck is joined by Sean Lau, a vascular access specialist at Stanford Health Care, to share strategies to help reduce DIVA rates and improve vascular access care.
Host: John E. Anderson, MD
Guest: Scott Pilla, MD, MHS
One of the most serious side effects of diabetes, hypoglycemia can lead to severe consequences, and keeping up with the latest in care can help us prevent this complication. To share the latest updates, Dr. John Anderson is joined by Lead Researcher Dr. Scott Pilla to share insights from his recent studies on hospital utilization and primary care communication for patients with diabetes.
Host: John J. Russell, MD
Guest: Drew Weissman, MD, PhD
Guest: Katalin Karikó, PhD
As mRNA technology continues to emerge and evolve, Penn Researchers Dr. Drew Weissman and Dr. Katalin Karikó join Dr. John Russell to take a deep dive into the future of mRNA technology.
Host: John J. Russell, MD
Guest: Joseph E. Bavaria, MD
Featuring a wide range of disciplines and a new approach to comprehensive care, what do we need to know about the Aorta Center at Penn Medicine? Dr. John Russell is joined by Dr. Joseph E. Bavaria to dive into this aortic program and discuss a new approach to comprehensive care.
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Michelle Hughes, MD
Over the past two decades, there has been an increasing need for GI hospitalists to help provide rapid access to care. Since then, GI hospitalists have become an important part to many healthcare systems and their approach to patient care. Joining Dr. Peter Buch to discuss the benefits and challenges that come along with the GI hospitalist role is Dr. Michelle Hughes, Assistant Professor of Medicine and Medical Chief of Quality and Safety for Digestive Health at Yale New Haven Health.
Host: Miguel A. Escobar, MD
Guest: Cindy Leissinger, MD
Guest: Guy Young, MD
Hemophilia A is an X-linked genetic disorder characterized by a deficiency in normal factor VIII resulting in an increased risk of bleeding. Repeated bleeds, notably in the joints, lead to chronic pain and loss of function. Joint damage can be prevented, at least in part, with prophylactic factor VIII replacement. Although factor VIII can be replaced, its intravenous administration is burdensome, which may impair adherence. Furthermore, about 30% of patients treated with factor VIII will develop inhibitors—neutralizing alloantibodies to factor VIII—making factor VIII replacement ineffective. Although patients with inhibitors can be treated with bypassing agents, these agents are expensive and less predictable than factor VIII.
However, there is now another option for both patients with and without inhibitors: bispecific antibody non–factor replacement prophylaxis. It is important for the interprofessional care team to be aware of how this treatment compares with traditional prophylactic agents, its safety and efficacy data, and how to appropriately incorporate prophylaxis therapy based on the latest real-world clinical data.
In this educational activity, an expert faculty will review and provide their interprofessional perspectives on currently approved prophylaxis therapy in hemophilia A, including the benefits of prophylaxis and adherence, real-world experience, and patient quality of life factors.
Host: Lisa K Moores, MD, FCCP, MACP
Guest: David Jiménez MD, PhD, FERS
Guest: Geert-Jan Geersing MD, PhD
Physicians are challenged in adopting the latest clinical guidelines and integrating new and existing treatment advances into practice when managing patients with VTE.
Host: Lisa Baumann Kreuziger, MD, MS
Guest: Marc Carrier MD, FRCPC
Guest: Rachel P. Rosovsky, MD, MPH
Although evidence corroborates the safety and efficacy of managing low-risk patients with VTE in outpatient settings through prophylactic extension, the majority of this subtype is still being treated in hospital settings.
Host: Stavros Konstantinides, MD, FRCP (Glasg)
Guest: Riyaz Bashir MD, FACC
Guest: Akhilesh Sista, MD, FSIR, FAHA
High risk patients and those with identifiable symptoms are not routinely receiving prophylaxis treatment that could prevent the development of VTE.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Emily Carroll, JD, MSW
The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.
Host: Jennifer Caudle, DO
Guest: Sarah Ali, MD
From working in a big city to taking on an assignment in a small mountain village, Dr. Sarah Ali from the Ventura County Medical Center joins Dr. Jennifer Caudle to talk about her adventures abroad with locum tenens and share key lessons she learned along the way.
Host: Jennifer Caudle, DO
Guest: Cheryl Campos, DNP, RN-BC, CEN, CPHQ
Difficult IV access (DIVA) is a term used to describe patients who require multiple attempts to cannulate a vein. And since the prevalence of DIVA can be as high as 59 percent, Dr. Jennifer Caudle speaks with Dr. Cheryl Campos about how we can better identify high-risk patients, how we can manage DIVA patients, and more.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Manish Thapar, MD, AGAF, FAASLD, FACG
Acute hepatic porphyria (AHP) is a rare genetic condition characterized by severe, diffuse abdominal pain and a broad range of seemingly unrelated symptoms. AHP presents differently in each patient, with symptoms that mirror those of more common conditions, making it difficult to diagnose. Although AHP can be misleading, it can be easy to detect once you know what to look for. Joining Dr. Charles Turck to discuss AHP signs and symptoms and when a doctor should consider AHP in a patient is porphyria expert Dr. Manish Thapar, gastroenterologist and associate professor of medicine in Philadelphia.
©2021 Alnylam Pharmaceuticals, Inc. All Rights Reserved. AS1-USA-01069
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Rachael Consoli, MD, MPH, FACOG
With years of missionary work under her belt, one OB-GYN is fighting to reduce maternal mortality in underserved communities around the world. Dr. Charles Turck is joined by Dr. Rachel Consoli, an OB-GYN surgeon and Hospitalist based at North Shore Medical Center, to share stories from her time serving medical missions around the globe.
Host: Matt Birnholz, MD
Guest: Ripal Patel, MD, MPH
Locum tenens can take you on an exciting journey, but you may encounter a few horror stories along the way. Joining Dr. Matt Birnholz to share his own challenging experiences—and how we can avoid them—is Dr. Rip Patel, founder and lead for Mercision Emergency Medicine, and Assistant Professor at the Baylor College of Medicine in Houston, Texas.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Hassan Bencheqroun, MD
Evaluating the need for therapy escalation can be challenging. So joining Dr. Charles Turck to help us understand how to escalate treatment for patients with chronic obstructive pulmonary disease is Dr. Hassan Bencheqroun, Assistant Professor of Medicine at the University of California Riverside School of Medicine.
This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.
Guest: Phil Lieberman, MD
Host: Jennifer Caudle, DO
Are you familiar with the role of serum tryptase testing in diagnosing idiopathic anaphylaxis and mastocytosis? What role does serum tryptase play in the ongoing management of patients who have anaphylactic reactions to insect venom, and are there different considerations when a patient has a known trigger? Expert faculty Dr. Phil Lieberman shares his insights on serum tryptase testing in clinical practice and its importance in assessing mast cell disorders and anaphylaxis. This moderated discussion is enhanced with animation, key takeaways, and support slides to provide an engaging learning experience.
Serum tryptase plays an important diagnostic role in the setting of mast cell activation resulting from a variety of causes, including mastocytosis and anaphylaxis. Emergency medicine specialists, allergists, and primary care providers serve as the first-line responders to patients experiencing the effects of mast cell activation. The measurement of tryptase levels helps confirm diagnoses and inform management decisions for these life-threatening disorders. To help physicians provide optimal evaluation and management, it is essential that they be knowledgeable regarding the appropriate use of tryptase testing in these clinical settings. This education enables multidisciplinary clinicians to identify patients at risk of mast cell activation due to a variety of causes and employ …
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Deborah Levine, MD, FCCP
To better understand whether or not corticosteroids should be incorporated in treatment for our patients with COPD, Dr. Charles Turck is joined by Dr. Deborah Jo Levine, a Professor of Medicine and Director of the Pulmonary Hypertension Center at the University of Texas Health.
This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.
Host: Andrea Singer, MD, FACP, CCD
Guest: Paul A. Anderson, MD
Guest: Susan V. Bukata, MD, FAOA, FAAOS
While there’s growing awareness among orthopedic surgeons that osteoporosis is the underlying cause of fractures, there is often a disconnect between this recognition and action in the form of treatment to prevent subsequent fractures. In this discussion, Drs. Andrea Singer, Paul Anderson, and Susan Bukata address the pathophysiology of osteoporosis and the need to identify patients at risk for additional fractures. Osteoporosis treatment (including pharmacotherapy) can play a critical role in preventing future fractures, but physicians must first recognize that fracture is a sentinel event and treat it as a call to action.
Guest: Cem Akin, MD, PhD
Host: Jennifer Caudle, DO
What is the risk of anaphylaxis following vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19)? Are you familiar with the role of serum tryptase testing in patients with a suspected anaphylactic reaction? Expert faculty, Dr. Cem Akin, discusses serum tryptase testing and its importance in assessing anaphylaxis in response to COVID-19 vaccination. This moderated discussion is enhanced with animation, key takeaways, and support slides to provide an engaging learning experience.
Serum tryptase plays an important diagnostic role in the setting of mast cell activation resulting from a variety of causes, including mastocytosis and SARS-CoV-2 vaccination. Emergency medicine specialists, allergists, and primary care providers serve as the first-line responders to patients experiencing the effects of mast cell activation. The measurement of tryptase levels helps confirm diagnoses and inform management decisions for these life-threatening disorders. This education enables multidisciplinary clinicians to identify patients at risk of mast cell activation due to a variety of causes and employ appropriate use of tryptase testing across acute and follow-up care settings.
Host: Paul P. Doghramji, MD, FAAFP
Guest: Mojgan Saber, MD
Can Locum Tenens be an option for healthcare professionals just completing their residency? Dr. Paul Doghramji is joined by Dr. Mojgan Saber to share her own experience as well as tips and tricks for residents looking at Locum Tenens right after residency.
Host: Mario R. Nacinovich, Jr., MSc
Guest: Randy Young, MD
Amid the surge of the Delta variant, critical care physician Dr. Randy Young is traveling to ICUs across the country to help treat patients. Tune in to hear Dr. Young share how this surge is impacting both patients infected with the variant and the healthcare professionals caring for them.
Host: Charles P. Vega, MD
Guest: Sateria Venable
Regional healthcare disparities are biases that are based on where people live. Are your patients’ treatment options being impacted and limited by their geographical location? Join us as our two experts discuss how to support broader policy issues and highlight the importance of diagnostic algorithms that have been developed with diverse input. These steps may be of value in your clinical practice to ensure all patients have equal access to care regardless of their epidemiologic, socioeconomic, or insurance circumstances.
Host: Cassandra B. Donnelly, DO
Guest: Charles P. Vega, MD
Post-exposure influenza prophylaxis should be a top-of-mind discussion with patients receiving an influenza diagnosis. Unfortunately, it remains an underused means to reduce secondary infections in at-risk households. Join Drs. Cassandra Donnelly and Charles Vega as they examine an extended patient case and offer practical strategies to overcome common clinical barriers surrounding post-exposure influenza prophylaxis, including how to match the right patient with the right antiviral treatment.
Guest: Susan Butler-Wu, PhD, D(ABMM), SM(ASCP)
Dr. Susan Butler-Wu, Associate Professor of Clinical Pathology and Director of Medical Microbiology at LAC+USC Medical Center, investigates the differences—and highlights the benefits—of PCR versus antigen testing for COVID-19.
Host: Cassandra B. Donnelly, DO
Guest: Charles P. Vega, MD
Antiviral agents are underutilized against influenza in clinical practice, a failure that places many patients, especially those with comorbidities, at high risk for influenza-associated complications. Join Drs. Cassandra Donnelly and Charles Vega as they explore management strategies for patients with symptomatic influenza, compare and contrast clinical applications for the available antiviral agents, and reflect upon the increasing use of these agents as post-exposure influenza prophylaxis.
Host: Jennifer Caudle, DO
Guest: Fulvio Pinelli, M.D., M.Sc.
For patients who’ve undergone an emergency cardiac procedure, the transition from emergency room to doctor’s office may be challenging. What can we do to bridge those vascular access gaps beyond the emergency setting? Dr. Jennifer Caudle is joined by Dr. Fulvio Pinelli, the director of the Vascular Access Center at the Careggi University Hospital in Florence Italy, to share some strategies for maintaining continuity of care.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Paul Nyirjesy, MD
Guest: Christina Muzny, MD
Diagnosing vaginal infections early and accurately is key, but are current testing methods for vaginal infections facilitating early diagnosis? Joining Dr. Charles Turck to help answer this question are Drs. Christina Muzny and Paul Nirjesky, who share their multidisciplinary viewpoints on vaginal infections and diagnostic practices in women’s health.
Guest: Barbara Van Der Pol, PhD, MPH
Dr. Barbara Van Der Pol, a Professor of Medicine in Infectious Diseases at The University of Alabama at Birmingham and Scientist at the Center for Women’s Reproductive Health briefly discusses how rapid testing could impact the treatment landscape for sexually transmitted infections.
Guest: Andy Arwari, MD
With more patients opting for home-based care over long-term, acute, and office-based care, it’s important that we align with our patients on what’s most important to them and how they want to be cared for, especially those who are nearing the end of life.
That’s why VITAS Medical Director, Dr. Andy Arwari, is here to share the purpose of goals-of-care conversations and how an app can aid in determining if an advanced illness patient is eligible for hospice.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Ana C Zamora Martinez, MD
The COVID-19 pandemic led many clinicians to make life-altering decisions. Dr. Ana Zamora, a pulmonary disease and critical care specialist, discusses her work with Locum Tenens and why she decided it was time for a change.
Host: Paul Doghramji, MD
Guest: Nadine Nakazawa, RN, BS
How does the patient-centric experience model for vascular access care differ from what we're used to doing, and what does it actually look like in practice? Joining Dr. Paul Doghramji to share what we need to know about the development and goals of patient-centered vascular access care is Ms. Nadine Nakazawa, a vascular access nurse specialist at Stanford Health Care.
Host: Jennifer Caudle, DO
Guest: Aryeh Shander, MD, FCCM, FCCP
Bleeding is the most common complication of anticoagulant use. And to better care for patients either experiencing acute bleeding or urgently needing surgery, it's critical that clinicians thoroughly understand how to assess, treat, and reverse anticoagulation. Dr. Jennifer Caudle sits down with Dr. Aryeh Shander to discuss some of the different considerations we should take into account when selecting a warfarin reversal option.
Please read full Prescribing Information for Kcentra®.
KCT-0033-APR21
Guest: Robert Gottlieb, MD, PhD, FACC
Guest: Marilyn Bulloch, PharmD, BCPS, FCCM
Guest: Tesha Seabra, MSN, RN
Host: Mimi Secor, DNP, FNP-BC, FAANP
As of February 2022, information originally presented in the original broadcast has been updated. Due to the rise of the omicron variant, two combination therapies no longer carry EUA: bamlanivimab+eteseviman and casirivimab+imdevimab.
Neutralizing monoclonal antibodies (mAbs) first received emergency use authorization (EUA) in November 2020 for treating at-risk patients with COVID-19, and the field has continued to evolve since that time. This presentation provides an update in the latest evidence showing reduced severe illness and hospitalization in patients treated with neutralizing mAbs. This presentation will also answer your questions from multidisciplinary expert perspectives in identifying EUA-appropriate patients and administering outpatient infusion therapies: Robert Gottlieb, MD, PhD; Marilyn Bulloch, PharmD, BCPS, FCCM; and Tesha Seabra, MSN, RN.
Host: Jennifer Caudle, DO
Guest: Kelly Cawcutt, MD
How has the COVID-19 pandemic changed vascular access paradigms in the intensive care unit? Joining Dr. Jennifer Caudle to share her story and lessons learned from the pandemic is Dr. Kelly Cawcutt, an Assistant Professor in the Department of Internal Medicine and the Associate Medical Director of Infection Control and Epidemiology at the University of Nebraska Medical Center.
Host: Shannon L. Meeks, MD
Guest: Jonathan C. Roberts, MD
Dr. Shannon Meeks and Dr. Jonathan Roberts give an overview of the treatments used for the management of hemophilia A and discuss the safety and efficacy of these treatments. Using a patient case, they illustrate the pharmacovigilance process and explain how to implement this important reporting structure into everyday practice.
Host: Shannon L. Meeks, MD
Guest: Cindy Leissinger, MD
Pharmacovigilance begins after clinical trials end and new therapies enter everyday practice. Due to the rarity of hemophilia, participation in clinical trials has necessarily been small, and so monitoring the safety of new hemophilia treatments is especially important. Continued surveillance of adverse drug reactions (ADRs) after approval is a responsibility that falls on all members of the care team.
Dr. Shannon Meeks and Dr. Cindy Leissinger discuss the importance of safety surveillance and monitoring for novel hemophilia A therapeutics. To give a better understanding of pharmacovigilance, this activity includes animation that breaks down the process and illustrates where your ADR reports go and what happens next.
Host: David Weisman, MD
Guest: Mijail D Serruya MD,PhD
Every 40 seconds: that’s how often someone in the United States has a stroke. And it’s not uncommon for many of these patients to experience impaired functionality for the rest of their lives. But now, thanks to the latest technology, could something that seems straight out of a science-fiction novel like brain-computer interfaces help us improve the aftereffects of a stroke? Joining Dr. David Weisman to discuss his research that sought to address that exact question is Dr. Mijail Serruya.
Host: Matthew J. Sorrentino, MD, FACC, FASH
There’s no denying that healthcare professionals across all specialties went above and beyond the call of duty during the COVID-19 pandemic. And cardiologists were no exception. That’s why Dr. Matthew Sorrentino is calling attention to those cardiologists who were nominated by their peers for ReachMD’s Heroes in Healthcare initiative.
Host: John Buse, MD, PhD
Guest: Antonios Douros, MD
Dr. John Buse joins Dr. Antonios Douros, Assistant Professor in the Department of Medicine at McGill University and research investigator at Lady Davis Institute in Montreal, Quebec, to discuss his latest research focusing on SGLT2 inhibitors and diabetic ketoacidosis risk.
Host: Jennifer Caudle, DO
Guest: Casey Lafferty, DO
Guest: Eder Hernández, DMSc, PA-C
With the ongoing COVID-19 pandemic threatening our health and adding burden to our healthcare system, it’s more important than ever to educate patients on the flu and its symptoms. Here to share tips on how we can help prepare for, diagnose and treat flu this season are Dr. Casey Lafferty and Physician Assistant Doctorate Dr. Eder Hernández.
This information is intended for US audiences only.
Host: Mimi Secor, DNP, FNP-BC, FAANP
Guest: Karen Bloch, MD, MPH, FIDSA, FACP
Guest: Jarrod W. Kile, RPh, BCPS
Hear from a multidisciplinary, interprofessional panel of experts on COVID-19 infusion therapies with virus-neutralizing monoclonal antibodies (mAbs). This activity features a clinical discussion of the Emergency Use Authorization criteria and data from real-world use of mAbs in ambulatory patients. Learn how this treatment reduces the chance of patients with COVID-19 developing severe illness and what could be done to effectively implement the outpatient delivery of mAbs to patients with COVID-19 in your practice.
Host: De De Gardner, DrPH, RRT, RRT-NPS, FAARC, FCCP
Guest: Stephanie Briney, DO
Despite widespread availability, only half of Americans received the flu shot last year. With that in mind, Dr. De De Gardner is joined by Dr. Stephanie Briney, Assistant Professor in Family, Community, and Preventive Medicine at the University of Arizona College of Medicine, Phoenix to discuss why Americans avoid getting the flu shot and how she approaches this in her practice.
Host: John J. Russell, MD
Guest: Rose George
Dr. John Russell is joined by Rose George, the author of the book “Nine Pints," to take an in-depth look into everything we know about blood.
Host: Linda Bernstein, Pharm.D.
The U.S. Food and Drug Administration issued an emergency use authorization, or EUA, for the Moderna COVID-19 vaccine. The second vaccination to achieve EUA designation, the Moderna vaccine will be distributed throughout the US for patients 18 years and older. In this episode of The Drug Report, Dr. Linda Bernstein discusses this newly-approved vaccine and how it compares to others.
Published December 29, 2020
Host: Linda Bernstein, Pharm.D.
The first vaccine to receive Emergency Use Authorization from the US Food and Drug Administration, this authorization allows the Pfizer-BioNTech COVID-19 vaccine to be distributed throughout the US. But what do we know about this vaccine? In this episode of The Drug Report, Dr. Linda Bernstein discusses the Pfizer-BioNTech COVID-19 vaccine.
Published December 18, 2020
Host: Jennifer Caudle, DO
Guest: Ian F. Parney, MD, PhD
With a variety of novel immunotherapy treatments emerging, the field of oncology care continues to grow and evolve. But when it comes to treating complicated diseases such as brain cancer, is immunotherapy the right option? Dr. Ian F. Parney, a neurosurgeon at Mayo Clinic in Rochester, Minnesota discusses treating brain tumors with immunotherapy and dives into different types of brain tumors, treatment options, and potential side effects.
With state-of-the-art research and laboratory facilities, Mayo Clinic experts are constantly seeking a greater understanding of brain tumors in order to improve patient care. A variety of clinical trials and other studies of tumor biology, neuropathology and epidemiology may be available to for brain tumor treatment at Mayo Clinic.
For more information about referring a patient to Mayo Clinic, please visit mayoclinic.org and for continuing medical education opportunities visit ce.mayo.edu.
Host: Linda Bernstein, Pharm.D.
To prevent the flu from spreading concurrently with COVID-19, The U.S. Food and Drug Administration has expanded the approved indication for baloxavir marboxil to include post-exposure prevention of influenza. On this episode of The Drug Report, Dr. Linda Bernstein dives into this oral anti-influenza drug.
Published December 2, 2020
Host: Linda Bernstein, Pharm.D.
With the spread of the COVID-19 pandemic, fewer children have received a measles vaccination, and progress towards eliminating this disease has halted. How can pharmacists encourage more pediatric measles vaccinations? In this episode of The Drug Report, Dr. Linda Bernstein takes a look at the vast number of children globally who’ve yet to receive this vaccine.
Published November 30, 2020
Host: Linda Bernstein, Pharm.D.
In light of the COVID-19 pandemic, the Centers for Disease Control and Prevention, or the CDC, plans to use pharmacies to increase access to the COVID-19 vaccine when it is ready for distribution. In this episode of The Drug Report, Linda Bernstein will explain the CDC’s recently-developed Vaccination Program Interim Playbook.
Published November 17, 2020
Host: Linda Bernstein, Pharm.D.
The Food and Drug Administration announced that Remdesivir is the first treatment for COVID-19 to receive their approval. To help us better understand this antiviral agent, Dr. Linda Bernstein discusses emerging studies uncovering the benefits and limitations of Remdesivir.
Published November 6, 2020
Host: Xavier Soler, MD, PhD
Guest: Nicola A. Hanania, MD, MS, FCCP
To help us address the current lack of awareness of uncontrolled or symptomatic asthma in all stages of the disease, Dr. Xavier Soler is joined by Dr. Nicola Hanania, Associate Professor of Pulmonary Medicine and Director of the Airway Clinical Research Center at Baylor College of Medicine in Houston, Texas. Together, they’ll discuss how we can better recognize and treat our patients with uncontrolled asthma.
A non-promotional, non-CME educational program brought to you by CHEST in collaboration with GlaxoSmithKline.
Host: Tom Corbridge, MD, FCCP
Guest: Navitha Ramesh, MD, FCCP
Now that long-acting muscarinic receptor antagonists (LAMAs) have entered the scene, Dr. Tom Corbridge is joined by Dr. Navitha Ramesh, a pulmonologist and critical care physician at UPMC, to review some patient cases demonstrating how LAMAs may be changing the way we approach step-up treatment for some patients with asthma.
A non-promotional, non-CME educational program brought to you by CHEST in collaboration with GlaxoSmithKline.
Guest: Anil Agarwal, MD
How can healthcare professionals at the forefront of the pandemic protect the vascular integrity of COVID-19 patients undergoing acute dialysis procedures? Here to walk us through his process step by step is Dr. Anil Agarwal from the Ohio State University Wexner Medical Center.
Published August 19, 2020
Host: Matt Birnholz, MD
Guest: Anil Agarwal, MD
The emergence of blood clotting and clogged equipment for vascular procedures is a more recent—and troubling—phenomenon that’s emerged from the COVID-19 pandemic. Tune in as Dr. Anil Agarwal from the Ohio State University Wexner Medical Center discusses these two challenges and strategies for overcoming them.
Published August 13, 2020
Host: Andrew Wilner, MD, FACP, FAAN
Guest: William W. Li, MD
How do the lungs of healthy patients differ from the lungs of patients with COVID-19 or the flu? That’s the exact question Dr. William Li wanted to answer, and now, he’s sharing the results of his study that was recently published in the New England Journal of Medicine.
Published August 12, 2020
Guest: Charles Turck, PharmD, BCPS, BCCCP
Against the backdrop of a global push to get more ventilators and other critical gear into the hands of healthcare professionals, some clinicians are opting out of using ventilators to treat their COVID-19 patients as several hospitals have reported unusually high death rates. Listen in as Dr. Charles Turck explains.
Published June 5, 2020
Host: Jennifer Caudle, DO
Guest: Todd Askew
What’s being done to address the range of issues like the PPE shortage, lack of testing, and financial shortfalls encountered during the COVID-19 pandemic? Here to share his team’s advocacy efforts to help tackle these and other challenges is Todd Askew, the American Medical Association's Senior Vice President of Advocacy.
Host: Joshua Sharfstein, MD
Host: Stephanie Desmon
Guest: Albert Wu, MD
It’s been a few months since COVID-19 first arrived in the US, so what have we learned? Dr. Albert Wu returns to the podcast with Stephanie Desmon to discuss social distancing fatigue, new symptoms and disease observations, hopes for treatment, and what we should expect in the coming months in terms of a “return to normal.”
Published May 13, 2020
Host: Tom Corbridge, MD, FCCP
Guest: Gary T. Ferguson, MD, F.C.C.P
Listen in as Dr. Tom Corbridge and Dr. Gary Ferguson discuss the challenges physicians and patients face when there is an underreporting of COPD symptoms. Together, they’ll also explore the ways physicians can overcome these obstacles and give their patients the appropriate treatment.
This episode is supported in part by an unrestricted/independent medical educational grant from GlaxoSmithKline.
Host: Victor Test, MD, FCCP
Guest: Andrew Klein, MS, RT
Tune in as Andrew Klein, a clinical nurse specialist in respiratory therapy, discusses his experiences caring for COVID-19 patients in a teamwork environment. Through these collaborations, the best care can be made available during this pandemic.
Published March 26, 2020
Host: Joshua Sharfstein, MD
Guest: Megan Hosey Mastalerz, PhD
The intensive care unit can be stressful for all patients, but those with COVID-19 face unique challenges when it comes to mental and cognitive health. Clinical psychologist Dr. Megan Hosey of the Johns Hopkins Hospital ICU talks with Stephanie Desmon about ICU delirium, COVID-19 stigma, and what longer term prognosis could look like for patients inside and after the ICU.
Published May 6, 2020
Host: Matt Birnholz, MD
Guest: April Taylor, MS, MHA, CPPS, CPHQ
Every organization has disaster preparedness plans for one-day and one-week events like fires, hurricanes, and earthquakes, but how do those plans come into play during a pandemic like COVID-19 when there isn’t an end date in sight? Joining Dr. Matt Birnholz to discuss this and more is April Taylor, Senior Director of Improvement and Project Management at the Children’s Hospital of Philadelphia.
Published May 13, 2020
Host: Matt Birnholz, MD
In the absence of a vaccine, researchers have reported the potential need for long-term social distancing measures through 2021. Tune in as Dr. Matt Birnholz breaks down these findings and what the potential impacts might be if these warnings are ignored.
Published May 11, 2020
Host: Joshua Sharfstein, MD
Guest: Yngvild K. Olsen, MD, MPH, DFASAM
Since the COVID-19 pandemic began, the opioid epidemic disappeared from headlines but not from reality. Dr. Josh Sharfstein talks to Dr. Yngvild Olsen, the medical director of an addiction treatment program in Baltimore and the Vice President of the American Society of Addiction Medicine, about how her clinic had to pivot to stay open while protecting both patients and staff, how federal regulations have shifted, and what the status of the epidemic is and might be post-COVID-19.
Disclosure: Medical school classmates, Dr. Sharfstein and Dr. Olsen are married.
Published April 30, 2020
Host: Mario R. Nacinovich, Jr., MSc
Guest: Renata Schiavo, PhD, MA
COVID-19 is constantly referred to as a global pandemic, but how often do you think of it as an info-demic? Or as a health equity issue? Joining Mario Nacinovich to give us a look at COVID-19 through a different lens is Dr. Renata Schiavo, Senior Lecturer, Columbia University Mailman School of Public Health, Department of Sociomedical Sciences and Founder and President of the Board of Directors of the Health Equity Initiative. Dr. Schiavo discusses common barriers faced by the most vulnerable populations and how we can protect them during and after the COVID-19 pandemic.
Published April 28, 2020
Host: Mario R. Nacinovich, Jr., MSc
Guest: Anthony Dragun, MD
Throughout this global pandemic, radiation oncologists are faced with the challenge of finding ways to continue administering the necessary cancer treatments while limiting their patients’ risk of exposure to COVID-19. Dr. Anthony Dragun from the MD Anderson Cancer Center is here to explain how that can be done and why these new approaches should be embraced even after the COVID-19 pandemic is over.
Published April 27, 2020
Host: Linda Bernstein, Pharm.D.
Join pharmacist Dr. Linda Bernstein as she highlights several articles from recent literature describing coagulopathies in severely ill COVID-19 patients in China. She explores the cause and effect theories behind these findings and whether the observed coagulopathies are due directly to the virus, the critically ill condition of the patient that predisposes them to thromboembolism, or some combination of the two.
Published April 24, 2020
Host: Joshua Sharfstein, MD
Guest: Beth Blauer
The COVID-19 dashboard run by the Johns Hopkins Center for Systems Science and Engineering has been a critical source of near real-time tracking of the spread of the novel coronavirus since it first emerged. Beth Blauer, Executive Director of Centers for Civic Impact and an expert on the public’s use of data and analytics, is part of the team that manages the map. Blauer talks to Dr. Josh Sharfstein about how the global dashboard originated, what new features have been added, and how the data can help individuals and officials make informed decisions for COVID-19 response.
Published April 14, 2020
Host: Linda Bernstein, Pharm.D.
Tune in as pharmacist Dr. Linda Bernstein looks at a few of the novel approaches researchers all over the world are taking to conquer the novel coronavirus in addition to evaluating what these approaches may mean for today and potential viral mutations going forward.
Published April 21, 2020
Host: Joshua Sharfstein, MD
Guest: Vernon Lee, PhD
Early on in the COVID-19 outbreak, Singapore quickly launched a robust response which included widespread testing, diligent contact tracing and quarantining, and isolation of all sick persons, even those with mild symptoms. Alumnus Dr. Vernon Lee, Director of Communicable Diseases at the Ministry of Health of Singapore, talks to Dr. Josh Sharfstein about how lessons from the 2003 SARS outbreak informed Singapore’s risk-based approach to staying a few steps ahead of the novel coronavirus.
Published April 7, 2020
Guest: Michael Greenberg, MD
Join dermatologist Dr. Michael Greenberg as he shares his unique view that blurs science and spirituality and how it’s helping him create stronger connections with patients.
Published April 10, 2020
Host: John J. Russell, MD
Guest: Diane E Custer, MD
As the COVID-19 pandemic continues to spread across our nation and the world, more and more patients are experiencing anxiety and depression. Joining Dr. John Russell to explain how we can console our patients—all while maintaining our own mental health along the way—is Dr. Diane Custer.
Published April 8, 2020
Host: Michael Greenberg, MD
To help alleviate pressure from hospitals that are experiencing a high influx of patients due to the COVID-19 pandemic, dermatologist Dr. Michael Greenberg decided to keep his doors open and is now sharing what it’s like to see patients during this outbreak.
Published April 3, 2020
Host: Matt Birnholz, MD
After the American College of Surgeons and the Surgeon General's suspension of non-emergent surgeries and procedures, Dr. Matt Birnholz explains the new guidelines and their impact on patients.
Published April 2, 2020
Host: Matt Birnholz, MD
In the absence of a vaccine or antivirals against COVID-19, controlling its transmission through social distancing has been an essential strategy. And to prove it, a team from the University of Western Australia conducted research using a simulation city which implemented social distancing versus a city without it. Dr. Matt Birnholz summarizes this study's staggering findings.
Published April 1, 2020
Host: Joshua Sharfstein, MD
Guest: Jennifer Nuzzo, MD
Guest: Tara Kirk Sell, PhD, MA
Guest: Lauren M. Sauer, MS
With COVID-19 beginning to spread via community transmission in the U.S. and the WHO raising its risk assessment to “very high,” experts from the Johns Hopkins School of Public Health and Johns Hopkins University School of Medicine offer insights on the growing global public health concern.
Featuring Dr. Jennifer Nuzzo and Dr. Tara Kirk Sell of the Johns Hopkins Center for Health Security and Lauren Sauer of the Johns Hopkins Office of Critical Event Preparedness and Response; moderated by Dr. Josh Sharfstein, Vice Dean of the Johns Hopkins Bloomberg School of Public Health and former secretary of Maryland's Department of Health.
Published March 3, 2020
Host: Matt Birnholz, MD
Reports from hospitals in multiple states speak to a rapidly diminishing supply of personal protective equipment, leading healthcare systems to adopt alternative solutions to the shortage. But will these approaches meet the rising demand, and will clinicians be adequately protected along the way?
Published March 23, 2020
Host: Jennifer Caudle, DO
Guest: Stanley Green, MD
Fresh out of residency and hesitant to sign a long-term contract, Dr. Stanley Green was exploring other options for his career. That’s when he discovered locum tenens work, which might just hold the key to achieving his inspiring lifelong goal.
Host: Jennifer Caudle, DO
Guest: Theresa Rand, PA
Burnout is unfortunately experienced by many professionals in the healthcare space today, and its effects cannot be underestimated. Take Theresa Rand, for instance. After over 20 years as a physician assistant, Theresa kept finding herself unhappy and exhausted, no matter the people or practice. But in the pursuit of change, she turned to locum tenens…and has never looked back.
Host: Matt Birnholz, MD
Guest: Wes Ely, MD, MPH
After surviving a critical illness, many patients look forward to their lives returning to normal, but unfortunately, that’s not always possible.
To uncover the far-reaching impacts of delirium, Dr. Matt Birnholz is joined by Dr. Wes Ely, Professor of Medicine and Co-Director of the Center for Critical Illness, Brain Dysfunction and Survivorship Center at Vanderbilt University’s School of Medicine which focuses on improving the lives and care of patients in the intensive care unit to ensure both physical and cognitive rehabilitation.
Host: John J. Russell, MD
Guest: Victoria Sweet, MD
After her father was admitted to the hospital with a wrong diagnosis and consequently received the wrong treatment, Dr. Victoria Sweet found that no doctor would speak with her face to face. This eye-opening experience left her with the following question: What has gone missing from medicine?
This became the motivation for her book, Slow Medicine: The Way to Healing. Dr. Sweet joins Dr. John Russell to divulge on the logic, love, and beauty of slowing down in healthcare.
Host: Jennifer Caudle, DO
Tune in as Dr. Jennifer Caudle provides an update on suicide rates in the United States.
Host: Brian P. McDonough, MD, FAAFP
Palliative and hospice care both have very important roles in healthcare, but unfortunately, they are often overlooked as resources.
Dr. Brian McDonough is joined by Chief Medical Officer of Samaritan Healthcare & Hospice Dr. Stephen Goldfine, who offers his perspective on the stigma surrounding these two areas of healthcare and recommendations on how to make the conversation easier for you and your patients.
Host: Jennifer Caudle, DO
The month of September is dedicated to raising awareness of sickle cell disease, which affects approximately 70,000 to 100,000 Americans each year. Here to tell us more about this prevalent condition and the various resources available is Dr. Jennifer Caudle.
Host: John J. Russell, MD
Guest: Judd Hollander, MD
In the early 1900s, about 40% of doctor visits were made in a patient’s home. Today, with the rise of telehealth technologies, more than 7 million patients are once again receiving care in the comfort of their own homes.
Join Dr. John Russell as he speaks with Dr. Judd Hollander, Associate Dean for Strategic Health Initiatives at Sidney Kimmel Medical College at Thomas Jefferson University and Professor and Vice Chair of Finance and Healthcare Enterprises in the Department of Emergency Medicine, on the benefits and risks of implementing telemedicine in your practice.
Host: Andrew Wilner, MD, FACP, FAAN
There is still a great deal to learn about the long term effects of blast injuries on military personnel. Emerging evidence suggests that exposure to a blast can produce both overt and subtle neurological consequences in the brain, but much remains unknown.
Host Dr. Andrew Wilner is joined by Dr. Jack Tsao, Director of Traumatic Brain Injury Programs for the US Navy Bureau of Medicine and Surgery, and Professor of Neurology at the University of Tennessee Health Science Center. He is a Captain in the United States Navy, and an expert in detection and prevention of traumatic brain injury in active duty military personnel.
Host: Shira Johnson, MD
Physicians spend their entire careers striving to heal sick patients. But when these care providers become patients themselves, the abrupt reversal of roles can make for difficult adjustments.
Host Dr. Shira Johnson sits down with Dr. John Mulligan, VP for Emergency Room Physicians Medical Group and a practicing emergency physician, to share his experience, takeaways, and advice for transitioning from doctor to patient.
Host: Matt Birnholz, MD
Guest: Luanne Freer, MD
Practicing medicine at 17,000 feet brings a unique set of challenges for doctors, including altitude-related sicknesses, IV fluids freezing, and the need for duct tape to serve as an essential medical tool.
Dr. Matt Birnholz chats with Dr. Luanne Freer, Founder and Director of Everest ER, a medical clinic at Mount Everest Base Camp serving Everest climbers, support staff, and the local Nepalese population.
To find out more information about Everest ER, please visit http://www.everester.org.
Host: John J. Russell, MD
Guest: H. Gilbert Welch, MD, MPH
The central problem with health care, according to physician and author Dr. H. Gilbert Welch, is that too much of it has too little value.
Host Dr. John Russell chats with Dr. Welch about his book Less Medicine, More Health: 7 Assumptions that Drive Too Much Medical Care and the issues of the American healthcare system today. They talk about how the American public has been sold the idea that seeking medical care is one of the most important steps to maintaining wellness. Dr. Welch argues that more medical care is not, in fact, well correlated with good health; by contrast, the opposite may be true.
Host: John J. Russell, MD
Host Dr. Russell sits down with Dr. Steven Hatch, an infectious disease specialist and author of the book, Inferno: a Doctor's Ebola Story, about his experience in Liberia during the heart of the Ebola crisis.
Dr. Steven Hatch first came to Liberia in November 2013, to work at a hospital in Monrovia. Six months later, several of the physicians Dr. Hatch had mentored and served with were dead or barely clinging to life, and Ebola had become a world health emergency. Hundreds of victims perished each week; whole families were destroyed in a matter of days; so many died so quickly that the culturally taboo practice of cremation had to be instituted to dispose of the bodies. With little help from the international community and a population ravaged by disease and fear, the war-torn African nation was simply unprepared to deal with the catastrophe.
A physician’s memoir about the ravages of a terrible disease and the small hospital that fought to contain it, Inferno is also an explanation of the science and biology of Ebola: how it is transmitted and spreads with such ferocity. And as Dr. Hatch notes, while Ebola is temporarily under control, it will inevitably re-emerge―as will …
Host: Laura Wingate
Guest: Kim Isaacs, MD
Some of the most severe complications associated with ulcerative colitis are toxic megacolon, bleeding, fulminant colitis, and perforation of the bowel, while abscesses, intestinal bleeding, fistulas are more commonly associated with Crohn’s disease. While the development of emergency complications in IBD is uncommon, it can be life-threatening and result in permanent organ damage.
On this episode focusing on IBD emergencies, host Laura Wingate, Vice President of Education, Support, and Advocacy at the Crohn’s & Colitis Foundation, welcomes gastroenterologist Dr. Kim Isaacs, Professor of Medicine and Co-director of the UNC Multidisciplinary Center for IBD Research and Treatment at University of North Carolina–Chapel Hill.
Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study
Nugent, Zoann PhD; Singh, Harminder MD, MPH; Targownik, Laura E. MD; Strome, Trevor MS; Snider, Carolyn MD, MPH; Bernstein, Charles N. MD
Background: To describe the patterns and predictors of emergency department (ED) attendance and post-ED hospitalization by persons with inflammatory bowel disease (IBD).
Methods: We linked the University of Manitoba IBD Epidemiology Database with the Emergency Department Information System of the Winnipeg Regional Health Authority to determine the rates of presentation to the ED by persons with IBD from January 01, 2009 to March 31, 2012. Incident cases were diagnosed during the study period and all others were considered prevalent cases. Multivariate logistic regression was used to determine predictors of attendance in the ED and for hospitalization within 2 days of ED attendance.
Results: The study population included 300 incident and 3394 prevalent IBD cases, of whom 76% and 49%, respectively, attended the ED at least once during the study period. Incident cases with Crohn's disease or with a history of opioid use were more likely to attend the ED. Those …
Host: John J. Russell, MD
Three out of four people addicted to heroin probably started on a prescription opioid, according to the director of the Centers for Disease Control and Prevention. In the United States alone, 16,000 people die each year as a result of prescription opioid overdose. But perhaps the most frightening aspect of the prescription drug epidemic is that it’s built on well-meaning doctors treating patients with real problems.
Host Dr. John Russell chats with Dr. Anna Lembke, Chief of Addiction Medicine and an Assistant Professor at Stanford University School of Medicine. Dr. Lembke is the author of Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop, exploring how the prescription drug epidemic is a symptom of a faltering health care system, the solution for which lies in rethinking how health care is delivered.
Host: John J. Russell, MD
What if Americans put aside their differences and worked together to fix America's broken healthcare system? What changes need to be made in order to make health care both accessible and affordable without compromising excellent quality of care standards for patients? These and other crucial questions form premise behind the book We CAN Fix Healthcare: The Future is NOW.
Host Dr. John Russell sits down with Dr. Stephen Klasko, President and CEO of Jefferson University and Jefferson Health and author of We CAN Fix Healthcare: The Future is NOW.
Host: Shira Johnson, MD
Opiate addiction is rapidly becoming one of the biggest health crises in the United States today. Opiates have killed more than 28,000 people in 2014 and opioid deaths outnumber motor vehicle accidents and gunshot fatalities.
Dr. Shira Johnson talks with Dr. Kenji Oyasu, the Executive Medical Director for Brightside Clinic in Northbrook, Illinois. They discuss common misconceptions about medically-assisted treatments for opiate addiction.
Host: Brian P. McDonough, MD, FAAFP
In the aftermath of mass violence, from September 11th to the Paris attack to the Orlando shooting, fear and confusion often dominate the public consciousness. Unfortunately, most clinicians are not trained in tactical medicine to respond in times of crisis such as these. But a small subset of survuval medicine experts are working to change this pattern.
Dr. Brian McDonough speaks with Dr. Joseph Alton, Fellow of the American College of Surgeons and the American College of OB/GYN, and author of The Survival Medicine Handbook: A Guide for When Help is Not on the Way. The two discuss key survival and disaster response considerations for clinicians caught in violently dangerous situations.
Host: Brian P. McDonough, MD, FAAFP
Each year more than 70 million post-surgical patients are prescribed opioids. Research shows 1 in 15 will go on to use the medications long term, potentially putting them at risk for addiction and overdose.
Host Dr. Brian McDonough sits down with Dr. Susan Downey, a board-certified plastic surgeon, to talk about opioid abuse and what alternative prescription options are available instead of narcotics.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Obstetrical emergency care units offer pregnant women highly-specialized emergency care as a better alternative to the traditional emergency room visit. These units have been proven to increase patient satisfaction and improve emergency room wait time lengths. Where are they being utilized, and what are the barriers to implementing them nationwide?
Host Renee Allen talks with guests Dr. Brian Gilpin, National Clinical Director of Operations for OB Hospitalists at Mednax National Medical Group, and Dr. Christopher Swain, Founder and Chief Medical Officer for Ob Hospitalist Group (OBHG). They discuss the benefits and challenges of obstretical emergency care units.
Host: Matt Birnholz, MD
Dr. Matt Birnholz sits down with Dr. Andrew Bern, an emergency physician and independent health care consultant in South Florida. They discuss the process of forming specialty sections in ACEP, and focus on Dr. Bern's role in the evolving Disaster Medicine subspecialty through his continuing work in Ecuador. Dr. Bern, a former member of ACEP's Board of Directors, is a founding member of the Disaster, Geriatric, Tactical, Telemedicine and Disaster medicine sections at ACEP.
Host: Matt Birnholz, MD
Dr. Matt Birnholz speaks with Dr. Angela Garnder, past president of ACEP and Chief of Operations, Quality and Patient Safety at University of Texas Southwest. They discuss the importance of social media in the health care industry and ways to utilize this platform to enhance patients' experiences in hospitals and beyond.
Host: Matt Birnholz, MD
Dr. Matt Birnholz sits down with Dr. Carl Schultz, Research Director at the Center for Disaster Medical Sciences at University of California, Irvine. Dr. Schultz is a Professor of Emergency Medicine at the UC Irvine and recipient of the Disaster Medical Science Award at ACEP. He talks about the challenges of securing funding for disaster relief in the field and the integration of citizen volunteers in a disaster incident.
Host: Matt Birnholz, MD
Joining Dr. Matt Birnholz to discuss the current landscape and future milestones for engaging ACEP's younger cohort of physicians is Dr. Paul Kivela, Vice President of ACEP. Dr. Kivela is managing partner of the Napa Valley Emergency Medical Group in California. Dr. Kivela has been actively involved in the ACEP council for more than 15 years and has worked with the Reimbursement Committee on fair payment issues and has been an ACEP councilor or alternate since 1994.
Host: Jennifer Caudle, DO
Guest: Nimesh Desai, MD
Complex aortic diseases, feared by clinicians and the general public alike, are often labeled "silent killers" due to their unnerving pattern for developing insideously prior to presenting as acute crises. Even more concerning, the symptoms of aortic diseases are typically vague and difficult to diagnose without a high degree of clinical suspicion. For these reasons, the speed of diagnosis and treatment can determine whether patients live or die from aortic disease. Host Dr. Jennifer Caudle welcomes Dr. Nimesh Desai, attending cardiac surgeon and Director of the Thoracic Research Program at the University of Pennsylvania, to discuss innovative medical and surgical approaches to complex aortic diseases. The two categorize these disease states specifically, examine which patient populations are at highest risk, and review methods to help clinicians reach faster life-saving diagnoses.
Host: Matt Birnholz, MD
Only a decade ago, emergency medicine was largely considered an afterthought in large-scale clinical trials. This oversight persisted for years despite the fact that a wide variety of time-sensitive clinical conditions under frequent study were diagnosed and treated predominantly in emergency departments. However, the last several years have witnessed a rapid evolution within this specialty, such that departments nationwide are now granted the means and resources to dedicate efforts exclusively toward advancing emergency medicine research.
From the floors of the American College of Emergency Physicians (ACEP) annual meeting in Boson, Dr. Matt Birnholz speaks with Dr. Philip Levy, Professor of Emergency Medicine & Physiology and Associate Chair for Research in the Department of Emergency Medicine at Wayne State University School of Medicine. Dr. Levy is Chair of the ACEP Research Forum, whose efforts to date have helped put emergency medicine research in the limelight. The two discuss origins, present objectives, and future horizons for this forum and its impact on clinical research advancement in the field.
Host: Matt Birnholz, MD
Joining Dr. Matt Birnholz on the floors of the American College of Emergency Physicians annual meeting in Boston, MA is Dr. Matt Bitner, Vice Chair of Medical Staff Affairs and Quality at the Greenville Health System in Greenville, SC. Dr. Bitner co-chaired and directed ACEP's InnovatED, an interactive exhibitional platform that gained rapid acclaim for its next-level medical simulation demonstrations. He talks about the unique development processes and educational applications for these programs, such as the popular Code Black simulation.
Host: Matt Birnholz, MD
The model of emergency medicine enshrines the principles of universality, portability, freedom of choice, and equity in care for all those who walk through the door. Yet despite accounting for only 2% of healthcare costs nationwide, emergency departments receives criticism for contributing to the financial crisis of American health care. Are these criticisms justified, or does the ED coversely represent a potential solution?
Joining Dr. Matt Birnholz to discuss emergency medicine's current and future roles in healthcare policy, accounting, and quality improvement is Dr. James C. Mitchiner, attending emergency physician at St. Joseph Mercy Hospital in Ann Arbor and clinical assistant professor of emergency medicine at the University of Michigan Medical School. He is also medical director at Michigan’s federally designated health care quality improvement organization. Dr. Mitchiner received the Colin C. Rorrie Jr., PhD Award for Excellence in Health Policy for a career dedicated to advocating for more efficient, affordable healthcare in America.
Host: Matt Birnholz, MD
Joining Dr. Matt Birnholz on the floors of the American College of Emergency Physicians annual meeting in Boston, MA is Dr. Sudave Mendiratta, Program Director of Emergency Medicine at the University of Tennessee College of Medicine and co-founder of InnovatED, an interactive exhibitional platform at ACEP featuring products and services vetted by a team of emergency physicians and showcased working together in a true-to-life environment. Dr. Mendiratta shares insights on InnovatED's mission to bolster future thinking, departmental design solutions, cutting-edge products and services, and best practices driving change in the ED.
Host: Matt Birnholz, MD
Dr. Matt Birnholz welcomes Dr. Clifton Callaway, Professor and Executive Vice Chairman of the Department of Emergency Medicine at the University of Pittsburg School of Medicine. Dr. Callaway received ACEP's Outstanding Contribution to Research Award for his more than two decades of research dedicated to improving brain resuscitation after cardiac arrest. He joins Dr. Birnholz to discuss a research-guided evolution in resuscitation protocols based on improved physiological understandings of secondary brain injuries, comas, and recoveries.
Host: Matt Birnholz, MD
Dr. Matt Birnholz is joined by Dean Wilkerson, Executive Director for American College of Emergency Physicians (ACEP). Mr. Wilkerson provides an overview of ACEP's highest priority initiatives and ongoing efforts from the organization's leadership to help advance emergency medical care nationwide. Topics of discussion include the following:
- Increasing awareness toward outcomes measures and reporting for improved quality of emergency care.
- Defining emergency medicine's vital role in the 'Medical Neighborhood' models of patient care.
- Understanding the controversies over balance billing in emergency departments, how this affects both patients and clinicians, and what can be done about it.
For more information about ACEP's strategic goals and activities, visit www.acep.org.
[Read the Article]
Out-of-hospital cardiac arrest is a major public health issue, accounting for approximately 200,000 deaths per year in the United States. A new study examined whether increased use of defibrillators and cardiopulmonary resuscitation (CPR) by first responders and bystanders could help increase survival for people who experience an out-of-hospital heart attack.
In recent years, statewide initiatives in North Carolina have encouraged improvement in the use of CPR and automated external defibrillators (AEDs) by training more members of the general public.
Bystander-initiated CPR was associated with a greater likelihood of survival with favorable neurologic outcome. The combination of bystander CPR and first responder defibrillation increased from 14 percent in 2010 to 23 percent in 2013. Results found, patients who received bystander or first responder interventions before arrival of the emergency medical services (EMS) were more likely to survive compared to those who received EMS intervention alone.
[Watch more videos of The JAMA Report]
JAMA Report videos provided pursuant to license. ©2015 American Medical Association, publisher of JAMA® and The JAMA Network® journals.
Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial Andrew Appelboam, FRCEM, Adam Reuben, FRCEM, Clifford Mann, FRCEM, James Gagg, FRCEM, Prof Paul Ewings, PhD, Andrew Barton, MSc, Trudie Lobban, MRCP, Mark Dayer, FRCP, Jane Vickery, MSc, Prof Jonathan Benger, MD on behalf of the REVERT trial collaborators
The Lancet. 2015; DOI:10.1016/S0140-6736(15)61485-4
Published Online: 24 August 2015
Background: The Valsalva manoeuvre is an internationally recommended treatment for supraventricular tachycardia, but cardioversion is rare in practice (5–20%), necessitating the use of other treatments including adenosine, which patients often find unpleasant. Researchers assessed whether a postural modification to the Valsalva manoeuvre could improve its effectiveness.
Methods: The study authors did a randomised controlled, parallel-group trial at emergency departments in England. They randomly allocated adults presenting with supraventricular tachycardia (excluding atrial fi brillation and flutter) in a 1:1 ratio to undergo a modified Valsalva manoeuvre (done semi-recumbent with supine repositioning and passive leg raise immediately after the Valsalva strain), or a standard semi-recumbent Valsalva manoeuvre. A 40 mm Hg pressure, 15 s standardised strain was used in both groups. Randomisation, stratified by centre, was done centrally and independently, with allocation with serially numbered, …
Host: John J. Russell, MD
Not too long ago, there was no coming back from death. But now, with revolutionary medical advances, death has taken on the appearance at times of just another serious complication. In Shocked, author Dr. David Casarett chronicles his exploration of the cutting edge of resuscitation and reveals just how far science has come. Dr. John Russell hosts.
This week, Mark and Margaret speak with Dr. Deane Marchbein, President of the American Board of Medecins Sans Frontieres (Doctors Without Borders). Dr. Marchbein joined MSF in 2006 to work as an anesthesiologist in MSF's surgical program in Ivory Coast. She has worked with MSF in Democratic Republic of Congo, Haiti, Libya, Nigeria, South Sudan, and Syria, and as a medical doctor in Libya and Lebanon.
Host: John J. Russell, MD
A New Orleans hospital, after Hurricane Katrina, was surrounded on all sides by several feet of water. The power was out, and as time went on without restoration of basic operations, rumors began circulating of the hospital being overrun by looters. It was a period of total chaos with breakdowns in institutional leadership, compromises in patient care, and in some cases, clinical decisions with deadly consequences. Dr. Sheri Fink, author of Five Days at Memorial: Life and Death in a Storm-Ravaged Hospital, takes us on a tour of the aftermath of these events, and the public outcries that both villified and defended the healthcare workers involved.
Click here for Part 1 of this fascinating two-part exploration of the disaster, a hospital's response, and the repercussions that have rippled through its affected staff, patients, and families years later.
Host: Frank Russomano
What are the continuing rehabilitation efforts in Haiti? And, how can you assist in the continual medical needs of this country? Host Frank Russomano welcomes pharmacist Ro Brual to discuss his special volunteer work in Haiti before, during and after the Haiti earthquake of 2010. Mr. Brual is a pharmacist and Associate Consultant of Medical Education at Eli Lilly & Company.
Host: John J. Russell, MD
In her book, Five Days at Memorial, physician and reporter Sheri Fink reconstructs 5 days at Memorial Medical Center and draws the reader into the lives of those who struggled mightily to survive and to maintain life amid chaos. Drawing from a culmination of six years of reporting, Dr. Fink unspools the mystery of what happened in those days, bringing listeners into a hospital fighting for its life and into a conversation about the most terrifying form of health care rationing.
Click here for Part 2 of this fascinating two-part exploration of the disaster, a hospital's response, and the repercussions that have rippled through its affected staff, patients, and families years later.
Host: Maurice Pickard, MD
Dr. Maurice Pickard welcomes author Scott McGaugh to discuss the subject of his book "Surgeon in Blue: Jonathan Letterman, the Civil War Doctor Who Pioneered Battlefield Care." Through their discussion, listeners will discover how one lone surgeon, Jonathan Letterman, reshaped military medicine over the course of four major Civil War battles and a single year. Letterman, confronted by thousands of wounded lying abandoned on the battlefield, a sickly and malnourished Union army, and obscenely filthy military camps, took steps that make battlefield survival possible for our soldiers today.
Host: Matt Birnholz, MD
Traumatic brain injury, or TBI, is a serious public health problem that affects approximately 1.7 million Americans every year. Of all injury deaths in our country, one in three cases are TBI-related, and an estimated 5.3 million Americans are living with a TBI-related disability. Beyond the potential for impairment to the cognitive, sensory, and motor functions in an individual, the economic burden of TBI is in excess of $76.5 billion. While significant advances in early treatment and prevention policies such as seat belt and motorcycle helmet laws have proven successful in reducing severe cases of TBI, many public health challenges remain. In addition to the economic impact of TBI, there is need for better surveillance, data, and coordination among the medical, public health and community sectors on both the civilian and military sides of the aisle.
This session of CDC′s Public Health Grand Rounds further addressed these challenges and explored promising policies, guidelines, and interventions such as progesterone treatments to further reduce the severity and number of cases of traumatic brain injury in the U.S.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part 3 >>
To view the complete video recording of …
Host: Bruce Japsen
Guest: Andrew Sama, Dr.
The emergency room has long been an entry point for medical care for the seriously injured, young parents with a sick child and increasingly poor uninsured Americans with nowhere to turn. But policymakers increasingly see the emergency room as less like those depicted on shows like Grey's Anatomy as a place for patients to abuse the system and run up costs. Dr. Andrew Sama, vice president of the American College of Emergency Physicians, tells host Bruce Japsen about how he thinks emergency doctors are beneficial to cost-effective medical care and why patients can and should turn to emergency departments.
Guest: David Hexter, MD, MPH, FACEP
Host: Gary Epstein
Host Gary Epstein's guest is Dr. David Hexter, practicing emergency physician in Baltimore and president of the Maryland State Medical Society (known as MedChi). He tells the story of his first spontaneous entrance into organized medicine. And he describes the transformation of emergency medicine since the 1980s and 90s, when treatments were much less sophisticated and the hospital emergency department was often starved of resources. Contrast with the recognition today that the emergency department is the public face — the front door — of the hospital.
This week's guest was nominated by:
Guest: Elizabeth Kovacs, PhD
Host: Timothy Bailey, MD
Experimental approaches, including the suppression of certain immune cells to speed difficult wounds, may lead healthcare professionals to advances in the treatment of diabetic wounds. What are the therapeutic strategies and implications for our patients with diabetes? Join guest host Dr. Timothy Bailey and his guest, director of research at the Burn & Shock Trauma Institute at Loyola University Medical Center, Dr. Elizabeth Kovacs, as they discuss the latest research in suppressing certain immune cells to speed healing of slow-to-heal wounds.
Guest: Simon Jensen, MBChB, FACEM, BSc(Hons), MSc(Dist)
Host: Mary Leuchars, MD
How common are snake bites in various parts of the world, and how many of these are venomous? What are the symptoms of envenomation, and how widely does the venom vary among snake species? Dr. Simon Jensen, founding director of the Global Snake Bite Initiative and clinical research supervisor at the University of Papua New Guinea's snake bite research project, discusses methods and treatments for snake bites. Dr. Mary Leuchars hosts.
Host: Anthony Alessi, MD
Guest: Eelco Wijdicks, MD, PhD
The American Academy of Neurology released new guidelines for determining brain death in adults, providing a step-by-step process for making this decision consistent among hospitals in the United States. One major departure in these guidelines is the recommendation of a single exam, rather than multiple exams occurring at several-hour intervals. How does this change impact organ donation following brain death? Dr. Eelco Wijdicks, professor of neurology at the Mayo Clinic College of Medicine and chair of the division of critical care, joins Dr. Anthony Alessi to discuss how to evaluate a brain dead patient without jeopardizing their organs for transplant.
Host: Anthony Alessi, MD
Guest: William Coplin, MD
The world witnessed a remarkable recovery after Congresswoman Gabrielle Giffords was shot in the head in an assassination attempt in January, 2011. However, most gunshot wounds to the head are fatal; statistics show only 5 percent of those shot in the head survive. Yet there are actions first responders and physicians can take to increase the chance of survival. Dr. William Coplin, associate professor of neurology and neurological surgery at Wayne State University in Detroit, Michigan, and director of neurotrauma and the neurological intensive care unit at Detroit Receiving Hospital, joins host Dr. Anthony Alessi to discuss what needs to be done in the "golden hour" after a shooting. He also focuses on the problems and rehabilitation issues patients face after this life-altering wound.
Guest: Donald Sefcik, MD
Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA
After many years of discussion, the National Commission on Certification of Physician Assistants (NCCPA) will offer PAs Certificates of Added Qualification in 5 specialties, beginning in 2011. Dr. Don Sefcik, chairman of the NCCPA, joins host Lisa Dandrea Lenell to explain what it takes to obtain certification, what the benefits are to PAs, and why the NCCPA decided to institute the certification now, with the nation's healthcare system in flux.
Guest: Edward Mello, Jr
Host: Mimi Secor, DNP, FNP-BC, FAANP
It takes the entire community working together to effectively respond to a disaster. Trained first responders and medical professionals are key to saving lives. Nurse practitioners and physician assistants play a vital role, but it's crucial that community agencies know your specialties and how you can to be best utilized before a disaster strikes. Nurse practitioner Lt. Colonel Ed Mello joins host Mimi Secor to discuss how advanced practice clinicians can be involved in disaster training and what goes into becoming part of a disaster team.
Guest: Angela Gardner, MD
Host: Bruce Japsen
As healthcare reforms take place, changes are also in the offing in the emergency department amid demands that EDs be able to turn attention from treatment of routine conditions to disasters and other true emergencies. Dr. Angela Gardner, president of the American College of Emergency Physicians, tells host Bruce Japsen about tomorrow's needs for the emergency department, which will have a greater role as health reform is implemented and patients seek primary care.
Guest: Thomas Kirsch, MD, MPH
Host: Maurice Pickard, MD
Triage isn't the only issue facing healthcare professionals during the acute phase of responding to a disaster: there are also the challenges of limited resources and staffing, as well as the mental and physical preparedness of the medical response team. Dr. Thomas Kirsch, co-director of the Center for Refugee and Disaster Response in the Johns Hopkins Bloomberg School of Public Health, assistant professor and the director of operations for the department of emergency medicine at the Johns Hopkins School of Medicine and deputy director of the Johns Hopkins Office of Critical Event Preparedness and Response, describes his on-the-ground experiences during the first few months after the Haiti earthquake and reflects on the acute phase of the response there. What are some of the lessons learned from Haiti that we can apply to future crises, and what parts of the response were effective? Our guest also discusses the need for ethical training for disaster response teams. Dr. Maurice Pickard hosts.
Guest: Jeremy Allen, PA-C
Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA
When patients go to the emergency department for a non-life-threatening emergency, it seems impossible to predict how long the wait could be to see a medical provider. But now patients in New Britain, Connecticut, can plan their care by checking their iPhone. Physician assistant Jeremy Allen talks with host Lisa Dandrea Lenell about his role as lead developer on an iPhone app for the Hospital of Central Connecticut. They discuss the benefits to patients and ER staff, as well as how to expand the technology for other medical sites.
Host: Anthony Alessi, MD
Guest: Mill Etienne, MD, MPH, CPH
Host Dr. Anthony Alessi interviews neurologist Lt. Cmdr. Mill Etienne, MD, at St. Damien's Pediatric Hospital in Port-au-Prince, Hati. Dr. Etienne is a Hatian-American physician in the United States military, stationed on the USNS Comfort. They discuss Dr. Etienne's work providing medical care, in addition to translation services and cultural sensitivity training for the staff on board the Comfort, and lessons he has brought from the American Academy of Neurology's Palatucci Advocacy Leadership Forum (which trains selected members to be effective advocates for patients at the local, state, and national levels.) At the end of the interview, find out how you can still help in Haiti.
Guest: Anthony Alessi, MD
Guest: Lewis Zirkle, MD
Host: Michael Greenberg, MD
Guest: Daniel Fitzgerald, MD
Several weeks after the devastating earthquake in Haiti, we revisit the medical response with three physicians, all with different specialties and all with a deep connection to Haiti. Hosts Dr. Matt Birnholz and Dr. Michael Greenberg speak with Dr. Anthony Alessi, host of ReachMD's NeuroFrontiers and a practicing neurologist, who traveled to Haiti on a medical mission. We also also speak with Dr. Lewis G. Zirkle, Jr., an orthopedic surgeon who introduced the SIGN (Surgical Implant Generation Network) program. Additionally, our hosts speak with Dr. Daniel Fitzgerald, from the Weill Cornell Medical College, about his work with Gheskio Relief in Haiti.
Host: Janet Wright, MD
Guest: Michael Mooney, MD
Therapeutic hypothermia is a relatively new treatment option for patients who suffer cardiac arrest, that can significantly improve neurologic outcomes. What factors determine the success of cooling therapy for cardiac arrest, and what resources does the procedure require? Dr. Michael Mooney, Director of Interventional Cardiology, Minneapolis Cardiology Associates, at Minneapolis Heart Institute / Abbott Northwestern Hospital in Minnesota, explores the indications for therapeutic hypothermia with host Dr. Janet Wright. Might therapeutic hypothermia be approached with a strategy similar to initiatives aimed at reducing door-to-balloon time for ST-elevation MI?
Guest: Thomas Krueger, MD
Host: Matt Birnholz, MD
Host: Michael Greenberg, MD
It is a long way from the tranquil hills of Tennessee to the war-torn streets of Nigeria, Darfur or Sri Lanka, but that path is the one chosen by surgeon Dr. Thomas Krueger. Dr. Krueger served overseas on four missions with Doctors Without Borders, the international medical organization, and has plans to go abroad again. He is also featured in the Academy Award-nominated documentary on the organization, Living in Emergency: Stories of Doctors Without Borders. In this discussion with the Second Opinion Live hosts, Dr. Krueger speaks about what he learned, how he helped, and why this service was important for him to perform.
Guest: Kevin Chung, MD
Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA
Guest: Charles Thompson, PA-C, RN
It takes a team of specialists, social workers, PAs, nurses and therapists to care for the burn patients at the US Army Burn Unit in Brooke Army Medical Center, Fort Sam Houston, Texas. Every day more than 30 medical professionals make rounds checking on the critically injured at the unit. Dr. Kevin Chung, intensivist at the burn center, and PA Charles Thompson explain to host Lisa Dandrea Lenell the mutli-disciplinary team approach that is used to treat more than 500 patients a year.
Guest: Irl Hirsch, MD, MACP
Host: Steven Edelman, MD
Lowering blood sugar levels in critically ill patients is a widely embraced practice. But according to the results of the NICE-SUGAR study, lowering blood glucose levels in ICU patients may not be safe. Join host Dr. Steven Edelman and his guest, Dr. Irl Hirsch, professor of medicine and the Diabetes Treatment and Teaching chair at the University of Washington in Seattle, as they discuss the results of the NICE-SUGAR study and its implications for treating critically ill patients.
Guest: Sheri Fink, MD, PhD
Host: Matt Birnholz, MD
Host: Michael Greenberg, MD
It has been several years since Hurricane Katrina wreaked havoc up and down the U.S. Gulf Coast, but the storm continues to leave a nasty legacy in its wake. As the levees broke and the city of New Orleans descended into chaos, the medical staff at Memorial Medical Center wondered whether help would come to evacuate their patients to safety. With conditions turning more extreme by the day, and supplies running short, the medical team faced truly extraordinary circumstances. What follows is a narrative of ethical twists and turns, the lessons from which are still being extracted to this day. ProPublica reporter Dr. Sheri Fink has worked tirelessly to investigate the saga at Memorial over the past two and a half years. She joins hosts Dr. Michael Greenberg and Dr. Matt Birnholz to share this story.
Dr. Birnholz and Dr. Greenberg will cover a range of other topics during the show, including the ongoing debate over patient responsibility: what kind of incentives might encourage patients to meet personal health goals, and who should provide these incentives? They will also pay tribute to a health care stalwart in the United States Senate, the late Massachusetts Senator Edward M. Kennedy.
Guest: Matt Baker, PhD, PA-C
Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA
When disaster strikes, the first instinct of a medical professional is to jump in and help; however, that's not necessarily the best tactic. Dr. Matt Baker, dean of the school of science and health at the University of Philadelphia, joins host Lisa Dandrea Lenell to discuss volunteer options for PAs in the event of a local or national disaster. The two also discuss state licensing issues and educational opportunities for PAs who may want to become first responders.
Guest: Shan Liu, MD
Host: Shira Johnson, MD
Patients that come into an emergency room sometimes have to wait hours even days before they are moved to a hospital floor. A new study says more than a quarter of patients who are "boarded" in the ER after being admitted to the hospital often suffer undesirable events like missing necessary treatments or medications. Dr. Shan Liu, an attending physician at Massachusetts General Hospital in Boston and an instructor at Harvard Medical School, joins Dr. Shira Johnson to discuss her study on this growing worldwide issue.
Guest: Michael King
Host: Bruce Japsen
The burgeoning number of emergency patients who do not speak English because our nation has become so diverse is creating a greater imperative to bridge the language gap in the hospital. Live video interpretation and translation could be the answer, says Michael King, director of business development for the Metropolitan Chicago Healthcare Council, in an interview with host Bruce Japsen of the Chicago Tribune.
Guest: Ed Lopez
Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA
What's it like to be a hospitalist? Many PAs are turning to this growing field. Ed Lopez, founder and president of La Palma Medicine and Surgical Associates in Tacoma, Washington, talks with host Lisa D'Andrea Lenell about the ins and outs of working in a hospital. They cover a typical day, and the type of personality best suited for this growing specialty.
Guest: Gloria Kuhn, MD
Host: Shira Johnson, MD
When should ER doctors become concerned about burnout? Many physicians show signs of career fatigue but continue to practice year after year. Dr. Gloria Kuhn, vice chair for academic affairs for the department of emergency medicine at Wayne State University, discusses her latest research with host Dr. Shira Johnson. Dr. Kuhn surveyed ER doctors to see what causes physicians to become unhappy in their jobs and the warning signs ER doctors and other physicians should look for to combat burnout.
Guest: Angela Gardner, MD
Host: Shira Johnson, MD
The practice of emergency room diversion began back in the late 1980s to help prevent overcrowding in busy hospitals. But does it still work? Hospitals across the country are so crowded today that ambulances are turned away regularly. Dr. Angela Gardner, president-elect of the American College of Emergency Physicians and assistant professor of emergency medicine at the University of Texas at Galveston, explores the issue of overcrowding and the policies designed to combat the problem, with host Dr. Shira Johnson.
Guest: Alex Rosenau, MD
Host: Shira Johnson, MD
Doctors and nurses in the emergency department work under constant stress. So, what happens when a case is so stressful and horrific that it affects medical personnel emotionally? Dr. Alex Rosenau, vice chair of the department of emergency medicine at Lehigh Valley Hospital and Health Network in Lehigh, Pennsylvania, joins host Dr. Shira Johnson to discuss techniques and counseling services to help ED staff deal with unusually brutal cases.
Guest: Arthur Derse, MD, JD
Host: Shira Johnson, MD
More than 500,000 Americans die from cancer every year, and many of those people spend their final hours in the emergency department. More and more patients and their families turn to ED doctors to help make difficult decisions when it comes to end-of-life issues. Dr. Arthur Derse, director of medical and legal affairs and associate director of the Medical College of Wisconsin's Center for the Study of Bioethics and professor of bioethics and emergency medicine, joins host Dr. Shira Johnson to look at how doctors can help terminally ill patients and their loved ones when it comes to living wills, life support and pain management.
Guest: William Thomas, MD
Host: Lee Freedman, MD
Why are conventional emergency departments less than ideal environments for older patients, and how can EDs be acclimated for seniors? Dr. William Thomas, geriatrician and professor of aging studies at the Erickson School at the University of Maryland, describes to host Dr. Lee Freedman the philosophy behind the nation's first ED designed specifically for older patients, at Holy Cross Hospital in Silver Springs, Maryland. How do staffing and design changes, as well as new screening methods, help physicians better care for older patients? Is this model cost-effective and efficient enough for other hospitals to emulate?
Guest: Vincent Bufalino, MD
Host: Bruce Japsen
CPR and AED can make the difference between life and death. But the varying degrees of knowledge and usage of these life-saving practices across the country may be putting people at risk for death from cardiac arrest. Dr. Vincent Bufalino, CEO of Midwest Heart Specialists, one of the biggest community cardiac physician groups in the country, and director of cardiovascular services at Edward Heart Hospital in the western Chicago suburb of Naperville, tells host Bruce Japsen about how doctors can lead communities in education and preparedness when it comes to CPR and AED. The results may astonish you.
Guest: Jack Franaszek, MD
Host: Shira Johnson, MD
Urgent care centers, boutique emergency rooms, free standing emergency departments and retail clinics: How do all of these non-traditional emergency facilities fit in the paradigm of emergency medicine? What works? What doesn't work? What is the best for the patient and for healthcare? Dr. Jack Franaszek, director of the emergency department at Lake Forest Hospital and clinical associate professor at University of Chicago, elaborates on the structure and the financial impact of the multi-tiered options of emergency care. He discusses how all of these tiers of acute healthcare are eating up dollars. And will it be for the better? Dr Shira Johnson hosts.
Guest: Michael Bresler
Host: Shira Johnson, MD
Do you know how to respond in your office to an unexpectedly elevated blood pressure in a patient not previously diagnosed with hypertension? Dr. Michael Bresler, professor in the division of emergency medicine at Stanford University School of Medicine and director of emergency medicine at the Mills-Peninsula Health System, discusses management of a new diagnosis of hypertension. Dr. Shira Johnson is the host as Dr. Bresler reviews a disease that affects over 60% of adults in the United States.
Guest: Joseph R. Lex, MD
Host: Shira Johnson, MD
What can we learn from cardiac markers such as troponin and troponin 1 in the emergency department and how will this dictate the decisions we make in caring for our patients? Dr. Joseph Lex, associate professor of medicine in the department of emergency medicine at Temple University School of Medicine in Philadelphia, joins host Dr. Shira Johnson to tell us what cardiac markers do and do not tell us. Is there a marker indicating unstable angina? What can we learn from delta cardiac markers, destabilization, and plaque rupture? And what information is most important in supporting an ED doc's clinical decision?
Guest: Marianne Gaushe-Hill, MD
Host: Shira Johnson, MD
When should your emergency medical services unit be transporting instead of treating? Dr. Marianne Gauche-Hill, professor of medicine at the David Geffen School of Medicine at UCLA and director of EMS at Harbor-UCLA Medical Center, reveals recent studies in the literature showing that less treatment may be more efficacious. Join Dr. Shira Johnson as she interviews Dr. Gauche-Hill to discuss scenerios when the diagnosis in the field may have a better outcome if ACLS care is delivered at the receiving facility.
Guest: Art Kellerman, MD
Host: Shira Johnson, MD
In a chaotic and uncontrolled environment, the emergency department is taking the lead in clinical research. Dr. Art Kellerman, professor of emergency medicine at Emory University, discusses how clinical trials performed in this challenging environment are shaping the future of the ED and of medicine. Dr. Shira Johnson hosts as Dr. Kellerman discusses his experiences at Grady Memorial Hospital, Atlanta's only public hospital and Level 1 trauma center, as one of the nation's leading emergency care researchers.
Host: Ketan Sheth, MD, MBA
Guest: Renata Engler, MD
How do insect allergies present challenges in emergency situations to first responders? What are the best ways to diagnose and treat anaphylaxis in patients away from a clinical setting? Host Dr. Ketan Sheth talks with Dr. Renata Engler, associate professor in the department of medicine at the Uniformed Services University of the Health Sciences, about treating insect allergy in the field. How is proper transport and storage of epinephrine particularly difficult for those in the military or others traveling to remote locations, and what can physicians do to ensure safety for patients in these situations?
Host: Shira Johnson, MD
Guest: Benjamin Abella, MD
Cardiac arrest management used to mean CPR and efforts that were often futile. Now more patients are surviving until discharge because of new techniques maximizing compressions and administering hypothermia. Join host Dr. Shira Johnson with Dr. Benjamin Abella, assistant professor in the department of emergency medicine at the University of Pennsylvania, to discuss the techniques on the forefront of resuscitation medicine that are having a positive effect on patient outcomes.
Guest: Richard Nicklas, MD
Host: Ketan Sheth, MD, MBA
What are the scenarios that characterize anaphylaxis, according to the National Institute of Health? Dr. Richard Nicklas, clinical professor of medicine at George Washington University Medical Center, discusses the manifestations of anaphylaxis and how physicians can best manage patients with a history of anaphylaxis. Dr. Ketan Sheth hosts.
Guest: Scott E. Rudkin, MD, MBA
Host: Shira Johnson, MD
Who will be there to take call in your emergency department? Dr Scott Rudkin associate professor of emergency medicine at the University of California, Irvine School of Medicine, is interviewed by Dr. Shira Johnson to discuss the on-call crises which may be impacting your emergency department. Dr. Rudkin discusses the instrumental causes which include low financial reimbursement, an increased risk of litigation in trauma cases, and a desire for a better lifestyle, all of which have taken their toll on emergency department call schedules.
Guest: Rita K. Cydulka, MD, MS
Host: Shira Johnson, MD
Seven percent of the adult population has diabetes, and these patients often present to primary care and emergency department physicians. What do you need to know about the medications these patients may already be taking, or that they may require once they're under your care? Understanding the effects, as well as potential complications, of the most current diabetes medications and devices is crucial when treating patients who have diabetes. Dr. Rita Cydulka, professor and vice-chair of the department of emergency medicine at Case Western Reserve University, joins host Dr. Shira Johnson to highlight the new medications and devices for managing diabetes. She also describes real-life presentations of patients who may be having problems with glucose management.
Guest: Rachel Chin, MD
Host: Shira Johnson, MD
Tattoos and body piercings have been around for hundreds of years. But now they are turning up in your office or your ED. Dr. Rachel Chin is a professor of emergency medicine at the University of California San Francisco School of Medicine. She and Dr. Shira Johnson look at the potential complications you may see and how to treat them.
Guest: John McConnell, PhD
Host: Shira Johnson, MD
The concept of the surgicalist was born of economic and practical necessity. Dr. John McConnell is a health economist and an assistant professor of emergency medicine at Oregon Health and Science University whose research has focused on emergency and trauma care as well as health policy. He is interviewed by Dr. Shira Johnson to discuss how and why the role of the surgicalist evolved. Tune in to find out who may be seeing your next surgical consult from the ED. It may not be the surgeon on call.
Guest: Vicki Noble, MD
Host: Beverly Hashimoto, MD
Dr. Vicki Noble, director of the Division of Emergency Ultrasound at Massachusetts General Hospital in Boston, discusses with host Dr. Beverly Hashimoto the importance of ultrasound in the critical care setting. In the emergency department, ultrasound can improve the physican's ability to administer appropriate treatment during the crucial "golden hour" of trauma. Dr. Noble also discusses six additional applications for ultrasound in the emergency department.
Guest: Jeanne Poole, MD
Host: Matthew J. Sorrentino, MD, FACC, FASH
Recent studies show that patients who receive an ICD shock, either appropriately or inappropriately, have a higher risk of death. Dr. Jeanne Poole, professor of Medicine and Cardiology at the University of Washington, Seattle shares with host, Dr. Matthew Sorrentino the prognostic importance of defibrillator shocks in patients with congestive heart failure.
Guest: James M Nicholson, MD,MSCE
Host: Lisa Mazzullo, MD
Over the last decade the rate of cesarean sections has increased from 22 percent to as much as 30 percent in some parts of the country. Cesarean risk increases with potential placental insufficiency and concerns about cephalo pelvic disproportion. How does AMOR-IPAT (active management of risk in pregnancy at term), a preventive induction technique, limit cesarean risk? Dr. James M. Nicholson, assistant professor in family practice and community medicine at the University of Pennsylvania School of Medicine, talks with host Dr. Lisa Mazzullo about this technique designed to prevent cesarean deliveries.
Guest: Richard Besser, MD
Host: Jennifer Shu, MD, FAAP
One major goal of the Centers for Disease Control and Prevention (CDC) is to help prepare the public for emerging health threats. What is the status of public health emergency preparedness at the federal, state and local levels? What progress has been made in preparing our country for natural, biological, chemical and other hazards? And in the context of progress, where is there room for improvement? Dr. Richard Besser, pediatrician and director of the CDC's Coordinating Office for Terrorism Preparedness and Emergency Response, addresses these questions and more with host Dr. Jennifer Shu.
Host: Bill Rutenberg, MD
Guest: James J. James, MD, DrPH, MHA
The spread of communicable diseases is prevalent following disasters. Joining host Dr. Bill Rutenberg for a conversation of new recommendations for vaccine preparedness to protect disaster survivors is Dr. James James. Dr. James is the director of the American Medical Association Center for Public Health Preparedness and Disaster Response and editor-in-chief of the journal Disaster Medicine and Public Health Preparedness.
Guest: Dave Gruber
Host: Susan Dolan, RN, JD
It's been almost a century since the outbreak of Spanish flu in 1918, arguably our most significant struggle with pandemic influenza. Dave Gruber, senior assistant commissioner for the division of health infrastructure preparedness and emergency response for the state of New Jersey, briefly chronicles the breadth of our 20th century pandemic encounters, and examines how these events apply to our evolving understanding of the public health consequences. Very simply, what defines a case of pandemic influenza? Mr. Gruber also updates us on the details of a potential vaccine for prospective Avian flu scenarios. Susan Dolan hosts.
Guest: Philip Smith, MD
Host: Mark Nolan Hill, MD
Guest: Lona Mody, MBBS
Providing healthcare in an influenza pandemic would likely bring an all-hands-on-deck approach. The staff at nursing homes and other care facilities would be enlisted to supply treatment to their own residents, likely in addition to outside patients requiring immediate assistance. How can nursing home institutions train their care providers for the specific demands of a pandemic flu scenario? What would be the special needs of nursing home residents during this time? For a closer look at these questions and more, host Dr. Mark Nolan Hill welcomes Dr. Philip Smith, professor and chief of infectious diseases at the University of Nebraska School of Medicine, and Dr. Lona Mody, assistant professor of internal medicine in the division of geriatric medicine at the University of Michigan Medical School.
Guest: Mauricio Lynn, MD
Host: Shira Johnson, MD
The threat of explosive device attacks is an everyday reality in Isreal. Dr. Mauricio Lynn, associate professor of surgery at the University of Miami Miller School of Medicine and director of the Trauma Resuscitation Unit at the Ryder Trauma Center at Jackson Memorial Hospital in Miami, served in the Israeli Defenses Forces for 18 years. He talks with host Dr. Shira Johnson about our preparedness for an explosive device attack on US soil. What have we learned from the experiences of Israelis and others?
Guest: Edward Pombier
Host: Shira Johnson, MD
Dr. Shira Johnson explores with Ed Pombier, director of the University of Miami Radiation Control Center at Jackson Memorial Hospital, the reality and the impact of a possible radiologic attack. Several years after September 11th, what do you really know about the aftermath of a dirty bomb?
Guest: Richard Weisman, PharmD
Host: Shira Johnson, MD
How would the survivors present after a nerve gas attack and what do you need to know to treat them? Dr. Richard Weisman, research associate professor of pediatrics at the University of Miami Miller School of Medicine and coordinator or the Weapons of Mass Destruction Response Program at the University of Miami Jackson Memorial Medical Center discusses the clinical picture of exposure to nerve gas. Dr. Shira Johnson is the host in this infomative session to teach you about the short and long term clinical effects and practical implications.
Guest: Derek Robinson, MD
Host: Maurice Pickard, MD
Emergency room visits nationwide are on the rise, even as the total number of emergency rooms is falling. Add this to the fact that, according to the Center for Disease Control and Prevention's recent publication, National Hospital Ambulatory Medical Care Survey: 2006 Emergency Department Summary, only 15.9 million out of 119 million visits to the emergency room in 2006 were urgent or emergent, and we see just how taxed our emergency rooms are. Dr. Derek Robinson, of the American College of Emergency Physicians, explores solutions to this expensive and inefficient way to provide care. Dr. Maurie Pickard hosts.
Guest: Peter Zed, PharmD
Host: Charles Turck, PharmD, BCPS, BCCCP
A range of factors likely contribute to the incidence of medication-related visits to the emergency room: a prescriber's instructions, a patient's adherence to those instructions, the drugs themselves, and much more. How serious are many of these events? How can medical professionals help prevent these episodes? Host Dr. Charles Turck probes these questions and beyond with Dr. Peter Zed, a pharmacotherapeutic specialist in emergency medicine and an associate professor in the department of emergency medicine and the College of Pharmacy at Dalhousie University in Halifax, Nova Scotia, Canada.
Guest: Lt. Col. Lorne Blackbourne, MD
Host: John Armstrong, MD
The United States Army Institute of Surgical Research (ISR) tracks every casualty from Iraq and Afghanistan, probing for injuries that may be preventable. One area of focus includes isolated extremity wounds. Col. Dr. Lorne Blackbourne, commander of the ISR in San Antonio, details key advances in field tourniquets and hemostatic agents that optimize outcomes for our soldiers. Are these products also being dispatched in civilian care settings? Find out more with host Dr. John Armstrong.
Guest: W. Frank Peacock, MD
Host: Shira Johnson, MD
Dr. W. Frank Peacock, vice chair in the Department of Emergency Medicine at the Cleveland Clinic Foundation, joins host Dr. Shira Johnson to discuss risk stratification after acute CHF. What does the first BNP really tell you? And what did the ADHERE trial discover about troponin and CHF?